Medications for human use with 5 or more active ingredients

Médicaments à usage humain avec 5 ingrédients actifs ou plus

Updated | Mise à jour : 2021-09-02
∙ Product Name | Nom du produit;
∙ Active ingredient(s) and concentration | Ingrédient(s) actif(s) et concentration;
∙ Original market date | Date de commercisalisation originale;
∙ Number of active ingredients | Nombre d’ingrédients actifs ;
∙ Route(s) of administration | Voie(s) d’administration;
∙ Dosage form(s) | Forme(s) posologique(s);
∙ AHFS;
∙ Schedule(s) | Annexe(s);
∙ Company | Entreprise;
∙ DIN:
Monograph | Monographie
∙ EXTRA STRENGTH TYLENOL COMPLETE COLD, COUGH & FLU PLUS MUCUS RELIEF NIGHTTIME;
∙ acetaminophen 1000 mg / 30 ml , dextromethorphan hydrobromide 30 mg / 30 ml , pseudoephedrine hydrochloride 60 mg / 30 ml , chlorpheniramine maleate 4 mg / 30 ml , guaifenesin 200 mg / 30 ml;
∙ 2011-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02365596
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85048
∙ COMPLETE LIQUID CAPSULES;
∙ acetaminophen 250 mg , guaifenesin 100 mg , dextromethorphan hydrobromide 10 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 325 mg , dextromethorphan hydrobromide 15 mg , pseudoephedrine hydrochloride 30 mg , doxylamine succinate 6.25 mg;
∙ 2012-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 8.00;
∙ Oral | Orale;
∙ Kit , Capsule | Trousse , Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02383365
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86912
∙ COLD & FLU;
∙ acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg;
∙ 2012-08-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Oral | Orale;
∙ Kit , Capsule | Trousse , Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02368536
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85348
∙ COLD & SINUS LIQUID CAPSULES;
∙ acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 325 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , doxylamine succinate 6.25 mg;
∙ 2016-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Oral | Orale;
∙ Kit , Capsule | Trousse , Capsule;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02427958
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91244
∙ COLD & FLU-IN-ONE;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg , acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
∙ 2012-04-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02368528
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85347
∙ FLU, COUGH & COLD COMPLETE DAY AND NIGHT;
∙ acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg , acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
∙ 2012-07-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02387697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87328
∙ BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU NIGHT;
∙ acetaminophen 500 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , chlorpheniramine maleate 2 mg / 15 ml , guaifenesin 100 mg / 15 ml;
∙ 2005-09-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02252376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73724
∙ BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COLD RELIEF NIGHT;
∙ acetaminophen 500 mg / 15 ml , dextromethorphan hydrobromide 15 mg / 15 ml , pseudoephedrine hydrochloride 30 mg / 15 ml , chlorpheniramine maleate 2 mg / 15 ml , guaifenesin 100 mg / 15 ml;
∙ 2011-08-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC;
∙ DIN: 02365618
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85049
∙ ACID CONCENTRATE D12286;
∙ acetic acid 10.8 g / l , dextrose 45 g / l , sodium chloride 263 g / l , potassium chloride 6.7 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217252
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20116
∙ NATURALYTE H-330;
∙ acetic acid 10.8 g / l , dextrose 49.49 g / l , sodium chloride 263 g / l , potassium chloride 10.06 g / l , calcium chloride 8.27 g / l , magnesium chloride 3.43 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81282
∙ SELECTBAG ONE (AX275G);
∙ acetic acid 36.0 g / l , dextrose 220.0 g / l , calcium chloride 51.5 g / l , potassium chloride 29.8 g / l , magnesium chloride 20.3 g / l;
∙ 2017-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02414899
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89952
∙ CLINIMIX;
∙ alanine 1656 mg / 100 ml , l-arginine 920 mg / 100 ml , glycine 824 mg / 100 ml , histidine 384 mg / 100 ml , dextrose 14 g / 100 ml , l-isoleucine 480 mg / 100 ml , l-leucine 584 mg / 100 ml , l-lysine hydrochloride 464 mg / 100 ml , methionine 320 mg / 100 ml , l-phenylalanine 448 mg / 100 ml , l-proline 544 mg / 100 ml , serine 400 mg / 100 ml , l-threonine 336 mg / 100 ml , tryptophan 144 mg / 100 ml , l-tyrosine 32 mg / 100 ml , l-valine 464 mg / 100 ml;
∙ 2020-11-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 16.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02498464
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98822
∙ CLINIMIX E;
∙ alanine 1656 mg / 100 ml , l-arginine 920 mg / 100 ml , glycine 824 mg / 100 ml , histidine 384 mg / 100 ml , l-isoleucine 480 mg / 100 ml , l-leucine 584 mg / 100 ml , l-lysine hydrochloride 464 mg / 100 ml , methionine 320 mg / 100 ml , l-phenylalanine 448 mg / 100 ml , l-proline 544 mg / 100 ml , serine 400 mg / 100 ml , l-threonine 336 mg / 100 ml , tryptophan 144 mg / 100 ml , l-tyrosine 32 mg / 100 ml , l-valine 464 mg / 100 ml , dextrose 14 g / 100 ml , sodium chloride 205 mg / 100 ml , potassium phosphate dibasic 261 mg / 100 ml , magnesium chloride 24 mg / 100 ml , calcium chloride 33 mg / 100 ml;
∙ 2020-12-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 20.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02498421
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98819
∙ OLIMEL 5.7%;
∙ alanine 8.24 g / l , l-arginine 5.58 g / l , l-aspartic acid 1.65 g / l , glutamic acid 2.84 g / l , glycine 3.95 g / l , histidine 3.4 g / l , l-isoleucine 2.84 g / l , l-leucine 3.95 g / l , olive oil 32 g / l , soybean oil 8 g / l , l-tyrosine 0.15 g / l , l-valine 3.64 g / l , dextrose 121 g / l , methionine 2.84 g / l , l-phenylalanine 3.95 g / l , l-proline 3.40 g / l , serine 2.25 g / l , l-threonine 2.84 g / l , tryptophan 0.95 g / l , lysine (l-lysine acetate) 4.48 g / l;
∙ 2011-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 20.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02352540
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83780
∙ MULTI-12/K1 PEDIATRIC;
∙ ascorbic acid (ascorbic acid) 80 mg / vial , vitamin a 2300 unit / vial , vitamin d 400 unit / vial , vitamin b1 (thiamine hydrochloride) 1.2 mg / vial , vitamin b2 (riboflavin-5-phosphate) 1.4 mg / vial , pyridoxine hydrochloride 1 mg / vial , nicotinamide 17 mg / vial , dexpanthenol 5 mg / vial , vitamin e (dl-alpha tocopheryl acetate) 7 unit / vial , vitamin k1 0.2 mg / vial , biotin 20 mcg / vial , folic acid 140 mcg / vial , vitamin b12 (cyanocobalamin) 1 mcg / vial;
∙ 2000-11-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 13.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 88:28.00 – MULTIVITAMIN PREPARATIONS;
∙ Prescription | Prescription;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02242529
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66277
∙ MULTI 12 INJECTION;
∙ ascorbic acid 20 mg / ml , vitamin a 660 unit / ml , vitamin d 40 unit / ml , vitamin b1 (thiamine hydrochloride) 0.6 mg / ml , vitamin b2 (riboflavin-5-phosphate) 0.72 mg / ml , nicotinamide 8 mg / ml , pyridoxine hydrochloride 0.8 mg / ml , dexpanthenol 3 mg / ml , vitamin e 2 unit / ml , biotin 12 mcg / ml , folic acid 80 mcg / ml , vitamin b12 (vitamin b12) 1 mcg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 12.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 88:28.00 – MULTIVITAMIN PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02100606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16462
∙ SPRAYGEL;
∙ avobenzone 2 % / w/w , octisalate 5 % / w/w , octocrylene 2.75 % / w/w , oxybenzone 2 % / w/w , homosalate 7.5 % / w/w;
∙ 2016-05-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447746
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93332
∙ BROAD SPECTRUM 30 SPF FPS SUNSCREEN LOTION;
∙ avobenzone 2.0 % / w/w , homosalate 10.5 % / w/w , octisalate 5.0 % / w/w , oxybenzone 2.0 % / w/w , octocrylene 2.0 % / w/w;
∙ 2013-06-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CROC BLOC PRODUCTS INC.;
∙ DIN: 02401355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88627
∙ SUNSCREEN FACE LOTION;
∙ avobenzone 2.5 % / w/w , homosalate 5 % / w/w , octisalate 4 % / w/w , octocrylene 3 % / w/w , oxybenzone 4 % / w/w;
∙ 2016-04-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447517
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93310
∙ LIFE BRAND SUNSCREEN FACE LOTION SPF 50+;
∙ avobenzone 2.7 % / w/w , homosalate 4 % / w/w , octisalate 4.5 % / w/w , octocrylene 6 % / w/w , oxybenzone 4.5 % / w/w;
∙ 2021-04-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02497816
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98761
∙ SUN LOGIC 30 FPS UVA UVB SPF HAUTE HIGH PROTECTION LARGE SPECTRE BROAD SPECTRUM CRÈME SOLAIRE VISAGE ET CORPS SUNSCREEN FACE AND BODY;
∙ avobenzone 2.85 % , homosalate 14 % , octinoxate 7.12 % , octisalate 4.75 % , octocrylene 9.5 %;
∙ 2019-04-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GUINOT;
∙ DIN: 02480476
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97099
∙ PUR CONFORT FPS 15 SPF;
∙ avobenzone 2.85 % , homosalate 5 % , octinoxate 7 % , octisalate 3 % , octocrylene 9 %;
∙ 2019-04-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GUINOT;
∙ DIN: 02480468
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97098
∙ DAILY SHEER BROAD-SPECTRUM SUNSCREEN SPF 50;
∙ avobenzone 3 % , homosalate 10 % , octinoxate 5 % , octisalate 5 % , octocrylene 3 %;
∙ 2017-05-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ZO SKIN HEALTH INC;
∙ DIN: 02460092
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94738
∙ ULTRA SHEER SUNSCREEN LOTION;
∙ avobenzone 3 % , homosalate 10 % , octisalate 3 % , octocrylene 7 % , oxybenzone 6 %;
∙ 2018-03-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02466791
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95515
∙ UNCOMPLIKATED SPF;
∙ avobenzone 3 % , homosalate 10 % , octisalate 5 % , octocrylene 10 % , oxybenzone 5 %;
∙ 2018-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KATE SOMERVILLE SKINCARE, LLC;
∙ DIN: 02465973
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95422
∙ FRESH ESSENTIALS DAILY NOURISHING MOISTURIZER;
∙ avobenzone 3 % / w/w , homosalate 12 % / w/w , octisalate 5 % / w/w , octocrylene 1.7 % / w/w , oxybenzone 3 % / w/w;
∙ 2011-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02355361
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84061
∙ LIFE BRAND SPORT SUNSCREEN CONTINUOUS SPRAY SPF 50+;
∙ avobenzone 3 % / w/w , homosalate 15 % / w/w , octisalate 5 % / w/w , octocrylene 10 % / w/w , oxybenzone 6 % / w/w;
∙ 2021-03-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02499053
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98882
∙ OLAY TOTAL EFFECTS 7-IN-1 ANTI-AGING MOISTURIZER WITH SUNSCREEN BROAD SPECTRUM SPF 30;
∙ avobenzone 3 % / w/w , homosalate 15 % / w/w , oxybenzone 6 % / w/w , octocrylene 2.6 % / w/w , octisalate 5 % / w/w;
∙ 2016-07-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02450607
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93676
∙ SPF 60 KIDS WET’N PROTECT;
∙ avobenzone 3 % / w/w , octocrylene 6 % / w/w , oxybenzone 3.9 % / w/w , homosalate 10.7 % / w/w , octisalate 3.2 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2019-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02470993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96009
∙ ULTRA SHEER FACE & BODY STICK SUNSCREEN SPF 50+;
∙ avobenzone 3 % / w/w , oxybenzone 3 % / w/w , homosalate 15 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w;
∙ 2016-01-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02434792
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91909
∙ BOBBI BROWN PRIMER PLUS PROTECTION SPF 50;
∙ avobenzone 3 % / w/w , oxybenzone 3 % / w/w , homosalate 5 % / w/w , octisalate 5 % / w/w , octocrylene 2.7 % / w/w;
∙ 2018-03-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DIST. BOBBI BROWN PROFESSIONAL COSMETICS;
∙ DIN: 02466511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95486
∙ BROAD SPECTRUM 50 SPF FPS SUNSCREEN LOTION;
∙ avobenzone 3.0 % / w/w , homosalate 13.0 % / w/w , octisalate 5.0 % / w/w , oxybenzone 4.0 % / w/w , octocrylene 7.0 % / w/w;
∙ 2013-06-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CROC BLOC PRODUCTS INC.;
∙ DIN: 02401436
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88633
∙ ANTI-AGING COMPLEX EMULSION BROAD SPECTRUM SPF 30;
∙ avobenzone 3.0 % / w/w , homosalate 8.0 % / w/w , octisalate 4.0 % / w/w , octocrylene 2.35 % / w/w , oxybenzone 5.0 % / w/w;
∙ 2013-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MERLE NORMAN COSMETICS INC;
∙ DIN: 02399113
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88402
∙ SUNSCREEN STICK SPF 50+;
∙ avobenzone 3.0 % / w/w , octisalate 5.0 % / w/w , octocrylene 10.0 % / w/w , oxybenzone 6.0 % / w/w , homosalate 15.0 % / w/w;
∙ 2014-03-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02416921
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90154
∙ ULTRA FLUIDE CORPS;
∙ bemotrizinol 5 % / w/w , drometrizole trisiloxane 7 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , homosalate 2 % / w/w , ensulizole 0.5 % / w/w;
∙ 2021-04-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02490404
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98045
∙ PREGVIT FOLIC 5;
∙ beta-carotene 1.6 mg , folic acid 5 mg , vitamin e (dl-alpha tocopheryl acetate) 13.8 mg , ascorbic acid (ascorbic acid) 120 mg , vitamin b1 (thiamine mononitrate) 3 mg , vitamin b2 (riboflavin) 3.4 mg , nicotinamide 20 mg , vitamin b6 (pyridoxine hydrochloride) 10 mg , d-pantothenic acid (calcium d-pantothenate) 5 mg , magnesium (magnesium oxide) 50 mg , iodine (potassium iodide) 0.15 mg , iron (ferrous fumarate) 35 mg , copper (cupric oxide) 2 mg , zinc (zinc oxide) 15 mg , vitamin b12 (cyanocobalamin) 12 mcg , vitamin d3 (cholecalciferol) 600 unit , calcium (calcium carbonate) 300 mg;
∙ 2016-08-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 17.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:28.01* – VITAMINS & MINERALS;
∙ Prescription | Prescription;
∙ DUCHESNAY INC;
∙ DIN: 02451581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93789
∙ PREGVIT;
∙ beta-carotene 1.6 mg , vitamin e (dl-alpha tocopheryl acetate) 13.8 mg , ascorbic acid (ascorbic acid) 120 mg , vitamin b1 (thiamine mononitrate) 3 mg , vitamin b2 (riboflavin) 3.4 mg , nicotinamide 20 mg , vitamin b6 (pyridoxine hydrochloride) 10 mg , d-pantothenic acid (calcium d-pantothenate) 5 mg , magnesium (magnesium oxide) 50 mg , iodine (potassium iodide) 0.15 mg , iron (ferrous fumarate) 35 mg , copper (cupric oxide) 2 mg , zinc (zinc oxide) 15 mg , folic acid 1.1 mg , vitamin b12 (cyanocobalamin) 12 mcg , vitamin d3 (cholecalciferol) 600 unit , calcium (calcium carbonate) 300 mg;
∙ 2016-07-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 17.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 88:28.01* – VITAMINS & MINERALS;
∙ Prescription | Prescription;
∙ DUCHESNAY INC;
∙ DIN: 02451573
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93788
∙ BI-PEGLYTE;
∙ bisacodyl 5 mg / tab , polyethylene glycol 3350 59.55 g / sachet , sodium sulfate 5.74 g / sachet , sodium bicarbonate 1.69 g / sachet , sodium chloride 1.46 g / sachet , potassium chloride 0.76 g / sachet;
∙ 2010-06-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet (Delayed-Release) , Kit , Powder For Solution | Comprimé (À Libération Retardée) , Trousse , Poudre Pour Solution;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Ethical | Spécialité Médicale;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 02326302
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81164
∙ HIGH PROTECTION LOTION SPF 50+;
∙ bisoctrizole 4.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 9.0 % / w/w , titanium dioxide 2.6 % / w/w , bemotrizinol 2.0 % / w/w;
∙ 2015-04-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PIERRE FABRE DERMO-COSMETIQUE CANADA INC;
∙ DIN: 02437236
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92153
∙ HIGH PROTECTION SPRAY SPF 50+;
∙ bisoctrizole 4.0 % / w/w , avobenzone 3.0 % / w/w , octocrylene 9.0 % / w/w , titanium dioxide 3.4 % / w/w , bemotrizinol 2.0 % / w/w;
∙ 2015-04-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PIERRE FABRE DERMO-COSMETIQUE CANADA INC;
∙ DIN: 02437309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92160
∙ AMO ENDOSOL SOLUTION;
∙ calcium chloride 0.048 % , magnesium chloride 0.03 % , potassium chloride 0.075 % , sodium acetate 0.39 % , sodium chloride 0.64 % , sodium citrate 0.17 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intraocular | Intraoculaire;
∙ Solution | Solution;
∙ 52:13.00* – ARTIFICIAL TEARS;
∙ Ethical | Spécialité Médicale;
∙ AMO CANADA COMPANY;
∙ DIN: 02007967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15177
∙ TPN ELECTROLYTES;
∙ calcium chloride 16.55 mg / ml , potassium chloride 74.55 mg / ml , magnesium chloride 25.4 mg / ml , sodium acetate 121 mg / ml , sodium chloride 16.05 mg / ml;
∙ 1983-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ PFIZER CANADA ULC;
∙ DIN: 00590215
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5535
∙ SELECTBAG ONE (AX200G);
∙ calcium chloride 29.4 g / l , potassium chloride 29.8 g / l , magnesium chloride 20.3 g / l , acetic acid 36 g / l , dextrose 220 g / l;
∙ 2016-11-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02414848
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89947
∙ SELECTBAG ONE (AX225G);
∙ calcium chloride 36.8 g / l , potassium chloride 29.8 g / l , magnesium chloride 20.3 g / l , acetic acid 36.0 g / l , dextrose 220.0 g / l;
∙ 2016-02-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02414856
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89948
∙ SELECTBAG ONE (AX2525G);
∙ calcium chloride 36.8 g / l , potassium chloride 37.3 g / l , magnesium chloride 20.3 g / l , acetic acid 36.0 g / l , dextrose 220.0 g / l;
∙ 2017-03-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02415496
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90009
∙ SELECTBAG ONE (AX325G);
∙ calcium chloride 36.8 g / l , potassium chloride 44.7 g / l , magnesium chloride 20.3 g / l , acetic acid 36.0 g / l , dextrose 220.0 g / l;
∙ 2016-02-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02414902
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89953
∙ SELECTBAG ONE (AX250G);
∙ calcium chloride 44.1 g / l , potassium chloride 29.8 g / l , magnesium chloride 20.3 g / l , acetic acid 36.0 g / l , dextrose 220.0 g / l;
∙ 2016-02-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02415461
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90007
∙ SELECTBAG ONE (AX350G);
∙ calcium chloride 44.1 g / l , potassium chloride 44.7 g / l , magnesium chloride 20.3 g / l , acetic acid 36.0 g / l , dextrose 220.0 g / l;
∙ 2016-01-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02415526
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90011
∙ SELECTBAG ONE (AX450G);
∙ calcium chloride 44.1 g / l , potassium chloride 59.6 g / l , magnesium chloride 20.3 g / l , acetic acid 36 g / l , dextrose 220 g / l;
∙ 2017-04-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02415488
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90008
∙ PRISMASOL 4;
∙ calcium chloride 5.145 g / 1000 ml , magnesium chloride 2.033 g / 1000 ml , dextrose anhydrous 22.00 g / 1000 ml , l-lactic acid 5.400 g / 1000 ml , sodium chloride 6.450 g / 1000 ml , sodium bicarbonate 3.090 g / 1000 ml , potassium chloride 0.314 g / 1000 ml;
∙ 2006-02-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Intravenous , Dialysis | Intraveineuse , Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02277476
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76310
∙ PRISMASOL 0;
∙ calcium chloride 5.145 g / 1000 ml , magnesium chloride 2.033 g / 1000 ml , lactic acid 5.4 g / 1000 ml , sodium chloride 6.45 g / 1000 ml , sodium bicarbonate 3.09 g / 1000 ml;
∙ 2001-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intravenous , Dialysis | Intraveineuse , Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02243095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66962
∙ ACID CONCENTRATE 2151;
∙ calcium chloride 6.24 g / l , sodium chloride 268 g / l , magnesium chloride 3.21 g / l , acetic acid 8.11 g / l , dextrose 90 g / l , potassium chloride 3.35 g / l;
∙ 1999-01-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02239486
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62960
∙ NATURALYTE H-402;
∙ calcium chloride 9.92 g / l , magnesium chloride 6.86 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l , sodium chloride 263 g / l , potassium chloride 6.71 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327422
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81275
∙ ADDNUTRIV;
∙ chromium (chromic chloride) 10 mcg / 10 ml , copper (cupric chloride) 380 mcg / 10 ml , iron (ferric chloride) 1100 mcg / 10 ml , manganese (manganese chloride) 55 mcg / 10 ml , iodine (potassium iodide) 130 mcg / 10 ml , fluoride (sodium fluoride) 950 mcg / 10 ml , molybdenum (sodium molybdate) 19 mcg / 10 ml , selenium (sodium selenite) 79 mcg / 10 ml , zinc (zinc chloride) 5000 mcg / 10 ml;
∙ 2020-12-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 9.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02497697
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98749
∙ OCTAPLEX;
∙ coagulation factor ii (human) 1520 unit / vial , coagulation factor vii (human) 960 unit / vial , coagulation factor ix (human) 1000 unit / vial , coagulation factor x (human) 1200 unit / vial , protein c 1240 unit / vial , protein s 1280 unit / vial;
∙ 2015-08-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H;
∙ DIN: 02434970
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91926
∙ BERIPLEX P/N 1000;
∙ coagulation factor ii (human) 1600 unit , coagulation factor vii (human) 1000 unit , coagulation factor ix (human) 1240 unit , coagulation factor x (human) 2040 unit , protein c 1640 unit , protein s 1360 unit;
∙ 2013-11-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02410826
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89540
∙ OCTAPLEX;
∙ coagulation factor ii (human) 760 unit / vial , coagulation factor vii (human) 480 unit / vial , coagulation factor ix (human) 500 unit / vial , coagulation factor x (human) 600 unit / vial , protein c 620 unit / vial , protein s 640 unit / vial;
∙ 2008-07-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intravenous | Intraveineuse;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H;
∙ DIN: 02294664
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78001
∙ BERIPLEX P/N 500;
∙ coagulation factor ii (human) 800 unit , coagulation factor vii (human) 500 unit , coagulation factor ix (human) 620 unit , coagulation factor x (human) 1020 unit , protein c 820 unit , protein s 680 unit;
∙ 2011-07-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intravenous | Intraveineuse;
∙ Powder For Solution | Poudre Pour Solution;
∙ 20:28.16 – HEMOSTATICS;
∙ Schedule D | Annexe D;
∙ CSL BEHRING CANADA INC;
∙ DIN: 02359251
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84428
∙ MULTI 1000;
∙ d-pantothenic acid (calcium d-pantothenate – riboflavin-5-phosphate) 2.6 mg / ml , ascorbic acid 100 mg / ml , vitamin a 1000 unit / ml , vitamin d 100 unit / ml , vitamin e (dl-alpha tocopheryl acetate) 1 unit / ml , vitamin b1 (thiamine hydrochloride) 4.5 mg / ml , vitamin b2 (riboflavin-5-phosphate) 1 mg / ml , nicotinamide 10 mg / ml , vitamin b6 (pyridoxine hydrochloride) 1.2 mg / ml;
∙ 1984-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 9.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 88:28.00 – MULTIVITAMIN PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 00586315
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5613
∙ LINESSA 28;
∙ desogestrel 0.1 mg , ethinyl estradiol 0.025 mg , desogestrel 0.125 mg , ethinyl estradiol 0.025 mg , desogestrel 0.15 mg , ethinyl estradiol 0.025 mg;
∙ 2006-06-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02257238
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74243
∙ ADDITIVE SOLUTION FORMULA 3 AS-3;
∙ dextrose 1.10 g / 100 ml , sodium citrate dihydrate 0.588 g / 100 ml , sodium chloride 0.410 g / 100 ml , sodium phosphate monobasic – monohydrate 0.276 g / 100 ml , citric acid monohydrate 0.042 g / 100 ml , adenine 0.030 g / 100 ml;
∙ 2013-05-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ 0-Unassigned | 0-Non Attribuée;
∙ Solution | Solution;
∙ 20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
∙ Ethical | Spécialité Médicale;
∙ TERUMO BCT, INC.;
∙ DIN: 02324393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80981
∙ DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM;
∙ dextrose 1.5 g / 100 ml , sodium chloride 538 mg / 100 ml , sodium lactate 448 mg / 100 ml , calcium chloride 18.3 mg / 100 ml , magnesium chloride 5.08 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00865095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10863
∙ DIANEAL PD 101 CAPD SOLUTION W 1.5% DEXTROSE;
∙ dextrose 1.5 g / 100 ml , sodium chloride 567 mg / 100 ml , sodium lactate 392 mg / 100 ml , calcium chloride 23.9 mg / 100 ml , magnesium chloride 15.2 mg / 100 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Liquid | Liquide;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00799815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10144
∙ CLINIMIX;
∙ dextrose 10 g / 100 ml , l-leucine hydrochloride 310 mg / 100 ml , l-phenylalanine hydrochloride 310 mg / 100 ml , l-lysine hydrochloride 290 mg / 100 ml , methionine 290 mg / 100 ml , l-alanine 1.04 g / 100 ml , glycine 1.04 g / 100 ml , l-arginine 520 mg / 100 ml , l-isoleucine 240 mg / 100 ml , l-valine 230 mg / 100 ml , histidine 220 mg / 100 ml , l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-proline 210 mg / 100 ml , l-tyrosine 20 mg / 100 ml;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 15.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02013932
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19610
∙ PHYSIONEAL 40 GLUCOSE 3.86% W/V 38.6MG/ML, SOLUTION FOR PERITONEAL DIALYSIS;
∙ dextrose 106.5 g / l , calcium chloride 0.507 g / l , magnesium chloride 0.14 g / l , sodium chloride 8.43 g / l , sodium bicarbonate 3.29 g / l , sodium lactate 2.63 g / l;
∙ 2003-08-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02247723
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71998
∙ CLINIMIX E;
∙ dextrose 16.6 g / 100 ml , l-leucine hydrochloride 310 mg / 100 ml , l-phenylalanine hydrochloride 310 mg / 100 ml , l-lysine hydrochloride 290 mg / 100 ml , methionine 290 mg / 100 ml , l-alanine 1.04 g / 100 ml , glycine 1.04 g / 100 ml , l-isoleucine 240 mg / 100 ml , l-valine 230 mg / 100 ml , histidine 220 mg / 100 ml , l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-proline 210 mg / 100 ml , l-tyrosine 20 mg / 100 ml , sodium acetate 205 mg / 100 ml , potassium phosphate dibasic 261 mg / 100 ml , sodium chloride 58.5 mg / 100 ml , magnesium chloride 24 mg / 100 ml , l-arginine 520 mg / 100 ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 19.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02013967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14076
∙ PHYSIONEAL 40 GLUCOSE 1.36% W/V 13.6MG/ML CLEAR-FLEX;
∙ dextrose 18.2 g / l , calcium chloride 0.245 g / l , magnesium chloride 0.068 g / l , sodium chloride 19.95 g / l , sodium bicarbonate 9.29 g / l , sodium lactate 6.73 g / l;
∙ 2013-02-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02368730
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85372
∙ DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM;
∙ dextrose 2.5 g / 100 ml , sodium chloride 538 mg / 100 ml , sodium lactate 448 mg / 100 ml , calcium chloride 18.3 mg / 100 ml , magnesium chloride 5.08 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00865109
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10864
∙ PHYSIONEAL 40 GLUCOSE 2.27% W/V 22.7 MG/ML CLEAR-FLEX;
∙ dextrose 30.3 g / l , calcium chloride 0.245 g / l , magnesium chloride 0.068 g / l , sodium chloride 19.95 g / l , sodium bicarbonate 9.29 g / l , sodium lactate 6.73 g / l;
∙ 2013-02-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02368757
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85374
∙ PHYSIONEAL 40 GLUCOSE 1.36% W/V 13.6MG/ML SOLUTION FOR PERITONEAL DIALYSIS;
∙ dextrose 37.5 g / l , calcium chloride 0.507 g / l , magnesium chloride 0.14 g / l , sodium chloride 8.43 g / l , sodium bicarbonate 3.29 g / l , sodium lactate 2.63 g / l;
∙ 2003-08-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02247721
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71993
∙ DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM;
∙ dextrose 4.25 g / 100 ml , sodium chloride 538 mg / 100 ml , sodium lactate 448 mg / 100 ml , calcium chloride 18.3 mg / 100 ml , magnesium chloride 5.08 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00865117
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10865
∙ DIANEAL PD 101 CAPD SOLUTION W 4.25% DEXTROSE;
∙ dextrose 4.25 g / 100 ml , sodium chloride 567 mg / 100 ml , sodium lactate 392 mg / 100 ml , calcium chloride 23.9 mg / 100 ml , magnesium chloride 15.2 mg / 100 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00799807
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10143
∙ DIANEAL PD 101 CAPD SOLUTION W 0.5% DEXTROSE;
∙ dextrose 500 mg / 100 ml , sodium chloride 567 mg / 100 ml , sodium lactate 392 mg / 100 ml , calcium chloride 23.9 mg / 100 ml , magnesium chloride 15.2 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00799793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10512
∙ PHYSIONEAL 40 GLUCOSE 3.86% W/V 38.6 MG/ML CLEAR-FLEX;
∙ dextrose 51.5 g / l , calcium chloride 0.245 g / l , magnesium chloride 0.068 g / l , sodium chloride 19.95 g / l , sodium bicarbonate 9.29 g / l , sodium lactate 6.73 g / l;
∙ 2013-02-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02368749
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85373
∙ PHYSIONEAL 40 GLUCOSE 2.27% W/V 22.7 MG/ML, SOLUTION FOR PERITONEAL DIALYSIS;
∙ dextrose 62.6 g / l , calcium chloride 0.507 g / l , magnesium chloride 0.14 g / l , sodium chloride 8.43 g / l , sodium bicarbonate 3.29 g / l , sodium lactate 2.63 g / l;
∙ 2003-08-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02247722
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71997
∙ SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE;
∙ dextrose 8.5 g / 100 ml , soybean oil 0.87 g / 100 ml , medium chain triglycerides (mct) 0.87 g / 100 ml , olive oil 0.72 g / 100 ml , fish oil 0.43 g / 100 ml , lysine (lysine acetate) 0.43 g / 100 ml , phenylalanine 0.33 g / 100 ml , leucine 0.48 g / 100 ml , valine 0.41 g / 100 ml , threonine 0.29 g / 100 ml , methionine 0.28 g / 100 ml , isoleucine 0.33 g / 100 ml , tryptophan 0.13 g / 100 ml , alanine 0.92 g / 100 ml , arginine 0.79 g / 100 ml , glycine 0.72 g / 100 ml , proline 0.73 g / 100 ml , histidine 0.2 g / 100 ml , serine 0.43 g / 100 ml , taurine 0.65 g / 100 ml , tyrosine 0.26 g / 100 ml;
∙ 2021-07-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 21.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02501775
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99138
∙ BOOSTRIX;
∙ diphtheria toxoid 2 unit / 0.5 ml , tetanus toxoid 20 unit / 0.5 ml , pertussis toxoid 8 mcg / 0.5 ml , filamentous haemagglutinin 8 mcg / 0.5 ml , pertactin 2.5 mcg / 0.5 ml;
∙ 2007-05-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:08.00 – TOXOIDS , 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02247600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71860
∙ BOOSTRIX-POLIO;
∙ diphtheria toxoid adsorbed 2.5 lf / 0.5 ml , tetanus toxoid adsorbed 5.0 lf / 0.5 ml , pertussis toxoid adsorbed 8 mcg / 0.5 ml , filamentous haemagglutinin adsorbed 8 mcg / 0.5 ml , pertactin adsorbed 2.5 mcg / 0.5 ml , inactivated poliovirus type i 40 d / 0.5 ml , inactivated poliovirus type ii 8 d / 0.5 ml , inactivated poliovirus type iii 32 d / 0.5 ml;
∙ 2010-10-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 8.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02312557
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79806
∙ SUNSCREEN CREAM SPF60;
∙ drometrizole trisiloxane 3.00 % / w/w , terephthalylidene dicamphor sulfonic acid 2.00 % / w/w , octocrylene 10.00 % / w/w , titanium dioxide 4.15 % / w/w , avobenzone 3.00 % / w/w;
∙ 2007-04-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02280388
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76605
∙ ULTRA FLUIDE VISAGE;
∙ drometrizole trisiloxane 7 % / w/w , bemotrizinol 5 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , homosalate 2 % / w/w , ensulizole 0.5 % / w/w;
∙ 2020-04-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02490021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98009
∙ LINESSA 21;
∙ ethinyl estradiol 0.025 mg , desogestrel 0.1 mg , ethinyl estradiol 0.025 mg , desogestrel 0.125 mg , ethinyl estradiol 0.025 mg , desogestrel 0.15 mg;
∙ 2006-06-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ ASPEN PHARMACARE CANADA INC.;
∙ DIN: 02272903
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75841
∙ TRI-JORDYNA 21;
∙ ethinyl estradiol 0.035 mg , norgestimate 0.18 mg , norgestimate 0.215 mg , ethinyl estradiol 0.035 mg , norgestimate 0.25 mg , ethinyl estradiol 0.035 mg;
∙ 2020-07-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02486296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97651
∙ TRI-JORDYNA 28;
∙ ethinyl estradiol 0.035 mg , norgestimate 0.18 mg , norgestimate 0.215 mg , ethinyl estradiol 0.035 mg , norgestimate 0.25 mg , ethinyl estradiol 0.035 mg;
∙ 2020-03-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ GLENMARK PHARMACEUTICALS CANADA INC.;
∙ DIN: 02486318
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97652
∙ ADACEL;
∙ filamentous haemagglutinin 5 mcg / 0.5 ml , pertussis toxoid 2.5 mcg / 0.5 ml , pertactin 3 mcg / 0.5 ml , diphtheria toxoid 2 lf / 0.5 ml , tetanus toxoid 5 lf / 0.5 ml , fimbriae types 2 and 3 (fim) 5 mcg / 0.5 ml;
∙ 1999-06-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:08.00 – TOXOIDS;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 02240255
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63789
∙ ADACEL-POLIO;
∙ filamentous haemagglutinin 5 mcg / 0.5 ml , pertussis toxoid 2.5 mcg / 0.5 ml , pertactin 3 mcg / 0.5 ml , tetanus toxoid 5 lf / 0.5 ml , fimbriae types 2 and 3 (fim) 5 mcg / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney 40 unit / 0.5 ml , inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1 8 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett 32 unit / 0.5 ml , diphtheria toxoid 2 lf / 0.5 ml;
∙ 2011-03-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 9.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 02352044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83726
∙ GLYCEROLYTE 57 SOLUTION;
∙ glycerine 57 g / 100 ml , sodium lactate 1.6 g / 100 ml , potassium chloride 30 mg / 100 ml , sodium phosphate monobasic 51.7 mg / 100 ml , sodium phosphate dibasic 124.2 mg / 100 ml;
∙ 1991-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ 0-Unassigned | 0-Non Attribuée;
∙ Solution | Solution;
∙ 92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI AG;
∙ DIN: 00783668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11330
∙ SMOFKABIVEN EXTRA NITROGEN;
∙ glycine 0.72 g / 100 ml , proline 0.73 g / 100 ml , histidine 0.2 g / 100 ml , serine 0.43 g / 100 ml , taurine 0.065 g / 100 ml , tyrosine 0.026 g / 100 ml , sodium acetate 0.16 g / 100 ml , potassium chloride 0.23 g / 100 ml , sodium glycerophosphate 0.23 g / 100 ml , magnesium sulfate 0.061 g / 100 ml , calcium chloride 0.028 g / 100 ml , zinc sulfate heptahydrate 0.00066 g / 100 ml , dextrose 8.5 g / 100 ml , soybean oil 0.87 g / 100 ml , medium chain triglycerides (mct) 0.87 g / 100 ml , olive oil 0.72 g / 100 ml , fish oil 0.43 g / 100 ml , lysine (lysine acetate) 0.43 g / 100 ml , phenylalanine 0.33 g / 100 ml , leucine 0.48 g / 100 ml , valine 0.41 g / 100 ml , threonine 0.29 g / 100 ml , methionine 0.28 g / 100 ml , isoleucine 0.33 g / 100 ml , tryptophan 0.13 g / 100 ml , alanine 0.92 g / 100 ml , arginine 0.79 g / 100 ml;
∙ 2021-05-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 27.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02501813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99142
∙ INFANRIX-HEXA;
∙ haemophilus influenzae type b-prp 10 mcg / 0.5 ml , filamentous haemagglutinin 25 mcg / 0.5 ml , pertactin 8 mcg / 0.5 ml , hepatitis b surface antigen (recombinant) 10 mcg / 0.5 ml , diphtheria toxoid 25 lf / 0.5 ml , tetanus toxoid 10 lf / 0.5 ml , inactivated poliovirus type i 40 unit / 0.5 ml , inactivated poliovirus type ii 8 unit / 0.5 ml , inactivated poliovirus type iii 32 unit / 0.5 ml , pertussis toxoid 25 mcg / 0.5 ml , tetanus toxoid adsorbed 40 mcg / 0.5 ml;
∙ 2008-12-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 11.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02253852
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73878
∙ CERAVE;
∙ homosalate 10 % / w/w , meradimate 5 % / w/w , octinoxate 5 % / w/w , octocrylene 2 % / w/w , zinc oxide 6.3 % / w/w;
∙ 2014-01-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CERAVE CANADA;
∙ DIN: 02410923
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89557
∙ SUNRIGHT 50;
∙ homosalate 10 % / w/w , octinoxate 7.5 % / w/w , octocrylene 6.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-04-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ NSE PRODUCTS INC.;
∙ DIN: 02475650
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96601
∙ SPF 30 ULTRA LIGHT ADVANCED WEIGHTLESS FACE LOTION;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , oxybenzone 3 % / w/w;
∙ 2014-01-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02412489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89709
∙ CLEAR STICK UV PROTECTOR;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , octinoxate 4.9 % / w/w , oxybenzone 3 % / w/w , avobenzone 2.5 % / w/w;
∙ 2017-11-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02463288
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95119
∙ HAWAIIAN TROPIC SILK HYDRATION WEIGHTLESS CLEAR SUNSCREEN SPRAY SPF 50 PLUS;
∙ homosalate 10 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w , avobenzone 3 % / w/w;
∙ 2019-01-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02478021
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96876
∙ SPF 50+ FPS ULTRA;
∙ homosalate 10 % / w/w , octocrylene 10 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2017-01-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EMPACK SPRAYTECH INC;
∙ DIN: 02449625
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93546
∙ LAIT SOLAIRE CORPS FPS 50+;
∙ homosalate 10 % / w/w , octocrylene 10 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2020-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLARINS CANADA INC;
∙ DIN: 02494469
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98447
∙ RODAN + FIELDS UNBLEMISH KIT;
∙ homosalate 10 % / w/w , octocrylene 10 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , benzoyl peroxide 2.5 % / w/w;
∙ 2021-03-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Gel , Kit , Lotion | Gel , Trousse , Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ RODAN & FIELDS LLC;
∙ DIN: 02513668
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100284
∙ CRÈME SOLAIRE VISAGE TOUCHER SEC FPS 50+;
∙ homosalate 10 % / w/w , octocrylene 2.7 % / w/w , avobenzone 3 % / w/w , octisalate 5 % / w/w , oxybenzone 6 % / w/w;
∙ 2020-05-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLARINS CANADA INC;
∙ DIN: 02494477
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98448
∙ SHEER LOTION SPF 60 BARE SKIN FEEL;
∙ homosalate 10 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 4 % / w/w , drometrizole trisiloxane 2.5 % / w/w , terephthalylidene dicamphor sulfonic acid 0.5 % / w/w;
∙ 2013-04-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02401916
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88679
∙ ULTRA SHEER WATER LIGHT;
∙ homosalate 10 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 7.5 % / w/w;
∙ 2010-02-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02331373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81708
∙ SPF 50+ ULTRA LIGHT ADVANCED WEIGHTLESS BODY LOTION;
∙ homosalate 10 % / w/w , oxybenzone 6 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , terephthalylidene dicamphor sulfonic acid 2 % / w/w;
∙ 2015-02-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02432595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91703
∙ ANTHELIOS LOTION CORPS ULTRA-FLUIDE;
∙ homosalate 10 % / w/w , oxybenzone 6 % / w/w , octisalate 5 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w , terephthalylidene dicamphor sulfonic acid 2 % / w/w;
∙ 2017-10-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02459515
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94683
∙ ANTHELIOS MIST;
∙ homosalate 10 % / w/w , oxybenzone 6 % / w/w , octocrylene 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , terephthalylidene dicamphor sulfonic acid 2 % / w/w;
∙ 2015-05-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02434415
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91875
∙ SPF 30 ANTHELIOS XL LOTION;
∙ homosalate 10.0 % / w/w , octocrylene 5.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , drometrizole trisiloxane 2.5 % / w/w , terephthalylidene dicamphor sulfonic acid 0.5 % / w/w;
∙ 2013-04-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02402130
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88700
∙ FPS 30 SOIN COMPLET;
∙ homosalate 10.0 % / w/w , octocrylene 5.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , drometrizole trisiloxane 2.5 % / w/w , terephthalylidene dicamphor sulfonic acid 0.5 % / w/w;
∙ 2014-01-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02410044
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89471
∙ SPF 60 ANTHELIOS XL LOTION;
∙ homosalate 10.0 % / w/w , octocrylene 7.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 4.0 % / w/w , drometrizole trisiloxane 2.5 % / w/w , terephthalylidene dicamphor sulfonic acid 0.5 % / w/w;
∙ 2013-05-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02402157
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88702
∙ FPS 60 SOIN COMPLET;
∙ homosalate 10.0 % / w/w , octocrylene 7.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 4.0 % / w/w , drometrizole trisiloxane 2.5 % / w/w , terephthalylidene dicamphor sulfonic acid 0.5 % / w/w;
∙ 2014-01-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02410060
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89473
∙ OMBRELLE KIDS LOTION WET’N PROTECT;
∙ homosalate 10.7 % / w/w , octocrylene 6 % / w/w , oxybenzone 3.9 % / w/w , octisalate 3.2 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2020-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02489155
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97925
∙ IDÉAL SOLEIL SPF 60;
∙ homosalate 10.72 % , octocrylene 6 % , oxybenzone 3.86 % , octisalate 3.21 % , avobenzone 3 % , drometrizole trisiloxane 0.5 %;
∙ 2017-03-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02459353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94656
∙ COMPLETE DRY MIST SPRAY;
∙ homosalate 10.72 % / w/w , octocrylene 6 % / w/w , oxybenzone 3.86 % / w/w , octisalate 3.21 % / w/w , avobenzone 3 % / w/w;
∙ 2014-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02415402
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90001
∙ SUPER FLUID UV DEFENSE SPF 50;
∙ homosalate 10.72 % / w/w , octocrylene 6 % / w/w , oxybenzone 3.86 % / w/w , octisalate 3.21 % / w/w , avobenzone 3 % / w/w;
∙ 2015-05-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02436434
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92077
∙ SUN PROTECTOR WEIGHTLESS LOTION FOR FACE AND BODY;
∙ homosalate 10.72 % / w/w , octocrylene 6 % / w/w , oxybenzone 3.86 % / w/w , octisalate 3.21 % / w/w , avobenzone 3 % / w/w;
∙ 2016-07-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02454246
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94075
∙ SPF 60 SPORT ENDURANCE;
∙ homosalate 10.72 % / w/w , octocrylene 6 % / w/w , oxybenzone 3.86 % / w/w , octisalate 3.21 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2016-02-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02447843
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93346
∙ LAIT SOLAIRE CORPS LOTION PROTECTRICE CORPS FPS 50 PLUS;
∙ homosalate 10.72 % / w/w , octocrylene 6 % / w/w , oxybenzone 3.86 % / w/w , octisalate 3.21 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2019-04-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BIOTHERM CANADA;
∙ DIN: 02477300
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96826
∙ BROAD SPECTRUM SPF/FPS 50;
∙ homosalate 11.7 % , oxybenzone 5.4 % , octocrylene 4.5 % , octisalate 4.5 % , avobenzone 3 %;
∙ 2017-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02444240
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92918
∙ POSITIVELY RADIANT DAILY MOISTURIZER;
∙ homosalate 12 % , octisalate 5 % , oxybenzone 3 % , avobenzone 3 % , octocrylene 1.7 %;
∙ 2007-01-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02283751
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76934
∙ HEALTHY DEFENSE DAILY MOISTURIZER SPF 45;
∙ homosalate 12 % / w/w , oxybenzone 6 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.35 % / w/w;
∙ 2007-07-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02291851
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77721
∙ SPF FPS 40 LOTION;
∙ homosalate 12.0 % / w/w , octinoxate 7.5 % / w/w , octocrylene 7.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w;
∙ 2015-03-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ HAIN-CELESTIAL CANADA, ULC;
∙ DIN: 02435489
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91979
∙ HEALTHY SKIN LIFT & FIRM;
∙ homosalate 12.0 % / w/w , octisalate 5.0 % / w/w , octocrylene 5.0 % / w/w , avobenzone 3.0 % / w/w , oxybenzone 3.0 % / w/w;
∙ 2011-06-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02359146
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84415
∙ SPF 45 SPORT CLEAR CONTINUOUS SPRAY;
∙ homosalate 13 % , octocrylene 7 % , avobenzone 5 % , octisalate 5 % , drometrizole trisiloxane 1 %;
∙ 2012-02-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02374196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85940
∙ ULTRA LIGHT ADVANCED CONTINUOUS SPRAY LOTION;
∙ homosalate 15 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2017-03-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02448718
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93442
∙ KIDS SUNSCREEN LOTION SPF/FPS 60;
∙ homosalate 15 % / w/w , octocrylene 10 % / w/w , oxybenzone 6 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2015-01-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02431610
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91610
∙ SPF 60 SPORT CLEAR CONTINUOUS SPRAY;
∙ homosalate 15 % / w/w , octocrylene 7 % / w/w , avobenzone 5 % / w/w , octisalate 5 % / w/w , drometrizole trisiloxane 2 % / w/w;
∙ 2012-02-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02374218
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85941
∙ COMPLETE SENSITIVE ADVANCED [80 MINUTES] WATER/SWEAT RESISTANT LOTION SPF 60;
∙ homosalate 15 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2019-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02465884
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95414
∙ ANTI-SHINE ANTHELIOS XL DRY TOUCH GEL-CREAM;
∙ homosalate 15 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2018-05-11;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02466376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95472
∙ ANTI-BRILLANCE LOTION TOUCHER SEC;
∙ homosalate 15 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2018-04-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02466406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95476
∙ SOIN SOLAIRE VISAGE CRÈME PROTECTRICE VISAGE FPS 50 PLUS;
∙ homosalate 15 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2019-04-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BIOTHERM CANADA;
∙ DIN: 02477319
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96827
∙ FACE ANTI-SHINE CREAM;
∙ homosalate 15 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2020-02-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02489589
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97966
∙ ULTRA SUN PROTECTION SPRAY;
∙ homosalate 15 % / w/w , oxybenzone 5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.5 % / w/w;
∙ 2017-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02454793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94155
∙ PRO-X BY OLAY DERMATOLOGICAL ANTI-AGING AGE PROTECTION LOTION SUNSCREEN BROAD SPECTRUM SPF 30;
∙ homosalate 15 % / w/w , oxybenzone 6 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.6 % / w/w;
∙ 2014-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PROCTER & GAMBLE INC;
∙ DIN: 02417332
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90196
∙ DENTEC LIP BALM;
∙ homosalate 4.5 % , octinoxate 7.4 % , meradimate 4.8 % , octisalate 5 % , oxybenzone 5.2 %;
∙ 2019-06-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DENTEC SAFETY SPECIALISTS INC;
∙ DIN: 02440784
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92514
∙ PROTECTIVE MOISTURIZER BROAD SPECTRUM SPF 30 SUNSCREEN;
∙ homosalate 5 % , octisalate 5 % , oxybenzone 5 % , avobenzone 3 % , octocrylene 2.7 %;
∙ 2016-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ HERBALIFE OF CANADA LIMITED;
∙ DIN: 02441993
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92636
∙ LA MER THE SPF 50 UV PROTECTING FLUID;
∙ homosalate 5.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , oxybenzone 3.0 % / w/w , octocrylene 2.7 % / w/w;
∙ 2014-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MAX HUBER RESEARCH LABS INC., DIST.;
∙ DIN: 02409976
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89463
∙ M.A.C PREP + PRIME FACE PROTECT LOTION SPF 50;
∙ homosalate 5.0 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , oxybenzone 3.0 % / w/w , octocrylene 2.7 % / w/w;
∙ 2015-01-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MAKE-UP ART COSMETICS, DIST.;
∙ DIN: 02415038
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89965
∙ SOIN SOLAIRE VISAGE CRÈME PROTECTRICE VISAGE FPS 30;
∙ homosalate 7 % / w/w , octocrylene 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2019-04-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BIOTHERM CANADA;
∙ DIN: 02477335
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96832
∙ ORIGINS A PERFECT WORLD SPF 40 AGE-DEFENSE MOISTURIZER WITH WHITE TEA;
∙ homosalate 8 % / w/w , octinoxate 7.5 % / w/w , octocrylene 5 % / w/w , octisalate 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2017-01-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ORIGINS NATURAL RESOURCES DIST;
∙ DIN: 02454262
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94078
∙ LAIT SOLAIRE CORPS LOTION PROTECTRICE CORPS FPS 30;
∙ homosalate 8 % / w/w , octocrylene 4.48 % / w/w , oxybenzone 2.88 % / w/w , octisalate 2.4 % / w/w , avobenzone 2.24 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2019-04-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BIOTHERM CANADA;
∙ DIN: 02477297
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96825
∙ SPF 30 KIDS WET’N PROTECT;
∙ homosalate 8 % / w/w , octocrylene 4.5 % / w/w , oxybenzone 2.9 % / w/w , octisalate 2.4 % / w/w , avobenzone 2.2 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2019-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02471345
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96046
∙ SUN PROTECTOR WEIGHTLESS LOTION FOR FACE AND BODY SPF 30;
∙ homosalate 8 % / w/w , oxybenzone 2.88 % / w/w , octisalate 2.40 % / w/w , octocrylene 4.48 % / w/w , avobenzone 2.24 % / w/w;
∙ 2015-05-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ KIEHLS CANADA;
∙ DIN: 02438550
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92293
∙ SPF 30 ULTRA LIGHT ADVANCED WEIGHTLESS BODY LOTION;
∙ homosalate 8.78 % / w/w , octocrylene 5.92 % / w/w , octisalate 4.88 % / w/w , avobenzone 2.96 % / w/w , terephthalylidene dicamphor sulfonic acid 0.5 % / w/w;
∙ 2016-03-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02447940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93361
∙ AGE MINIMIZE 3D DAY CREAM SPF 30 BROAD SPECTRUM SUNSCREEN;
∙ homosalate 9 % / w/w , octisalate 4.5 % / w/w , oxybenzone 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 3 % / w/w;
∙ 2018-07-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MARY KAY COSMETICS LTD;
∙ DIN: 02459086
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94624
∙ VOLU-FIRM DAY CREAM SUNSCREEN BROAD SPECTRUM SPF 30;
∙ homosalate 9 % / w/w , octocrylene 4 % / w/w , octisalate 4.5 % / w/w , oxybenzone 4.5 % / w/w , avobenzone 3 % / w/w;
∙ 2019-11-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MARY KAY COSMETICS LTD;
∙ DIN: 02460459
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94781
∙ Q10TM/MC POWER ANTI-WRINKLE;
∙ homosalate 9 % / w/w , octocrylene 7 % / w/w , octisalate 4.5 % / w/w , avobenzone 2.85 % / w/w , ensulizole 2.5 % / w/w;
∙ 2016-01-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02431440
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91586
∙ ANEW HYDRA FUSION DAILY BEAUTY DEFENSE;
∙ homosalate 9.5 % , octinoxate 7.5 % , oxybenzone 4.8 % , avobenzone 2.8 % , octocrylene 2.6 %;
∙ 2019-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02481804
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97228
∙ ROTATEQ;
∙ human-bovine rotavirus reassortant type g1 2210000 unit / dose , human-bovine rotavirus reassortant type g2 2840000 unit / dose , human-bovine rotavirus reassortant type g3 2220000 unit / dose , human-bovine rotavirus reassortant type g4 2040000 unit / dose , human-bovine rotavirus reassortant type p1(8) 2290000 unit / dose;
∙ 2006-10-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Solution | Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 02284413
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76999
∙ DALMACOL;
∙ hydrocodone bitartrate 1.65 mg / 5 ml , etafedrin hydrochloride 16.65 mg / 5 ml , sodium citrate 200 mg / 5 ml , alcohol anhydrous 0.25 ml / 5 ml , doxylamine succinate 6 mg / 5 ml;
∙ 1997-03-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Syrup | Sirop;
∙ 48:08.00 – ANTITUSSIVES , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Narcotic (Cdsa I) | Stupéfiant (Lrcdas I);
∙ LABORATOIRE RIVA INC.;
∙ DIN: 02230769
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50030
∙ COLD + SINUS DAYTIME COLD + SINUS NIGHTTIME;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
∙ 2014-05-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02388030
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87360
∙ ADVIL COLD & SINUS CONVENIENCE PACK;
∙ ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , ibuprofen 200 mg , pseudoephedrine hydrochloride 30 mg , chlorpheniramine maleate 2 mg;
∙ 2014-11-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 04:04.20 – PROPYLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC;
∙ DIN: 02399733
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88459
∙ PRIMENE 10%;
∙ l-leucine 1 g / 100 ml , l-lysine 1.1 g / 100 ml , l-valine 760 mg / 100 ml , l-isoleucine 670 mg / 100 ml , l-phenylalanine 420 mg / 100 ml , histidine 380 mg / 100 ml , l-threonine 370 mg / 100 ml , l-cysteine 189 mg / 100 ml , methionine 240 mg / 100 ml , tryptophan 200 mg / 100 ml , taurine 60 mg / 100 ml , l-tyrosine 45 mg / 100 ml , glutamic acid 1 g / 100 ml , l-arginine 840 mg / 100 ml , l-alanine 800 mg / 100 ml , l-aspartic acid 600 mg / 100 ml , serine 400 mg / 100 ml , glycine 400 mg / 100 ml , l-proline 300 mg / 100 ml , l-ornithine dihydrochloride 318 mg / 100 ml;
∙ 1997-11-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 20.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02236875
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60165
∙ CLINIMIX;
∙ l-proline 340 mg / 100 ml , serine 250 mg / 100 ml , glycine 515 mg / 100 ml , l-tyrosine 20 mg / 100 ml , dextrose 10 g / 100 ml , l-leucine 365 mg / 100 ml , l-phenylalanine 280 mg / 100 ml , lysine (l-lysine hydrochloride) 290 mg / 100 ml , methionine 200 mg / 100 ml , l-isoleucine 300 mg / 100 ml , l-valine 290 mg / 100 ml , histidine 240 mg / 100 ml , l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-alanine 1.04 g / 100 ml , l-arginine 575 mg / 100 ml;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 16.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02142279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20302
∙ CLINIMIX;
∙ l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-proline 210 mg / 100 ml , l-tyrosine 20 mg / 100 ml , dextrose 20 g / 100 ml , l-leucine hydrochloride 310 mg / 100 ml , l-phenylalanine hydrochloride 310 mg / 100 ml , l-lysine hydrochloride 290 mg / 100 ml , methionine 290 mg / 100 ml , l-alanine 1.04 g / 100 ml , glycine 1.04 g / 100 ml , l-arginine 520 mg / 100 ml , l-isoleucine 240 mg / 100 ml , l-valine 230 mg / 100 ml , histidine 220 mg / 100 ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 15.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02013940
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18550
∙ CLINIMIX;
∙ l-valine 230 mg / 100 ml , histidine 220 mg / 100 ml , l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-alanine 1040 mg / 100 ml , glycine 1040 mg / 100 ml , l-arginine 520 mg / 100 ml , l-proline 210 mg / 100 ml , l-tyrosine 20 mg / 100 ml , dextrose 16.6 g / 100 ml , l-leucine hydrochloride 310 mg / 100 ml , l-phenylalanine hydrochloride 310 mg / 100 ml , methionine 290 mg / 100 ml , l-lysine (l-lysine hydrochloride) 290 mg / 100 ml , l-isoleucine 240 mg / 100 ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 15.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02046709
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19143
∙ CLINIMIX;
∙ l-valine 230 mg / 100 ml , histidine 220 mg / 100 ml , l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-proline 210 mg / 100 ml , l-tyrosine 20 mg / 100 ml , l-isoleucine 240 mg / 100 ml , dextrose 5 g / 100 ml , l-leucine hydrochloride 310 mg / 100 ml , l-phenylalanine hydrochloride 310 mg / 100 ml , l-lysine hydrochloride 290 mg / 100 ml , methionine 290 mg / 100 ml , l-alanine 1.04 g / 100 ml , glycine 1.04 g / 100 ml , l-arginine 520 mg / 100 ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 15.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02013886
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14077
∙ TRIQUILAR 28;
∙ levonorgestrel 125 mcg , ethinyl estradiol 30 mcg , ethinyl estradiol 40 mcg , levonorgestrel 50 mcg , ethinyl estradiol 30 mcg , levonorgestrel 75 mcg;
∙ 1987-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 00707503
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8123
∙ TRIQUILAR 21;
∙ levonorgestrel 50 mcg , ethinyl estradiol 30 mcg , levonorgestrel 75 mcg , ethinyl estradiol 40 mcg , levonorgestrel 125 mcg , ethinyl estradiol 30 mcg;
∙ 1987-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ BAYER INC;
∙ DIN: 00707600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8124
∙ 20% PROSOL;
∙ lysine (lysine acetate) 1.35 g / 100 ml , histidine 1.18 g / 100 ml , isoleucine 1.08 g / 100 ml , leucine 1.08 g / 100 ml , phenylalanine 1 g / 100 ml , threonine 0.98 g / 100 ml , dl-methionine 0.76 g / 100 ml , tryptophan 0.32 g / 100 ml , alanine 2.76 g / 100 ml , glycine 2.06 g / 100 ml , arginine 1.96 g / 100 ml , proline 1.34 g / 100 ml , glutamic acid 1.02 g / 100 ml , serine 1.02 g / 100 ml , l-aspartic acid 0.6 g / 100 ml , tyrosine 0.05 g / 100 ml , valine 1.44 g / 100 ml;
∙ 1996-10-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 17.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02141450
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43947
∙ PEGLYTE POWDER;
∙ macrogol 238.18 g / bottle , sodium sulfate 22.96 g / bottle , sodium bicarbonate 6.76 g / bottle , sodium chloride 5.85 g / bottle , potassium chloride 3.05 g / bottle;
∙ 1988-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Ethical | Spécialité Médicale;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00777838
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9351
∙ BALANCE 1.5% GLUCOSE, 1.25 MMOL/L CALCIUM;
∙ magnesium chloride 0.1017 g / l , dextrose 16.5 g / l , sodium chloride 5.64 g / l , sodium lactate 3.925 g / l , calcium chloride 0.1838 g / l;
∙ 2006-07-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE CANADA INC;
∙ DIN: 02261057
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74647
∙ ACID CONCENTRATE 2116;
∙ magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 67.54 g / l , calcium chloride 6.24 g / l , sodium chloride 263 g / l;
∙ 1988-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00774936
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10114
∙ ACID CONCENTRATE D12316;
∙ magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 90 g / l , calcium chloride 6.24 g / l , sodium chloride 263 g / l , potassium chloride 3.35 g / l;
∙ 1996-11-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02178168
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34881
∙ ACID CONCENTRATE 2182;
∙ magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 89.99 g / l , calcium chloride 6.24 g / l , sodium chloride 262.98 g / l , potassium chloride 10.06 g / l;
∙ 1996-09-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02210835
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36836
∙ DIANEAL PD 101 CAPD SOLUTION W 2.5% DEXTROSE;
∙ magnesium chloride 15.2 mg / 100 ml , dextrose 2.5 g / 100 ml , sodium chloride 567 mg / 100 ml , sodium lactate 392 mg / 100 ml , calcium chloride 23.9 mg / 100 ml;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00799823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10009
∙ ACID CONCENTRATE A1269;
∙ magnesium chloride 2.14 g / l , acetic acid 10.81 g / l , dextrose 74.25 g / l , potassium chloride 6.71 g / l , sodium chloride 263 g / l , calcium chloride 5 g / l;
∙ 2019-07-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02262568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74794
∙ CLINIMIX E;
∙ magnesium chloride 24 mg / 100 ml , glycine 1.04 g / 100 ml , dextrose 10 g / 100 ml , l-leucine hydrochloride 310 mg / 100 ml , l-phenylalanine hydrochloride 310 mg / 100 ml , l-lysine hydrochloride 290 mg / 100 ml , methionine 290 mg / 100 ml , l-alanine 1.04 g / 100 ml , l-arginine 520 mg / 100 ml , l-isoleucine 240 mg / 100 ml , l-valine 230 mg / 100 ml , histidine 220 mg / 100 ml , l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-proline 210 mg / 100 ml , l-tyrosine 20 mg / 100 ml , sodium acetate 205 mg / 100 ml , potassium phosphate dibasic 261 mg / 100 ml , sodium chloride 58.5 mg / 100 ml;
∙ 1993-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 19.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02014076
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14075
∙ ACID CONCENTRATE D12299;
∙ magnesium chloride 3.21 g / l , acetic acid 10.8 g / l , dextrose 67.5 g / l , sodium chloride 263 g / l , potassium chloride 5.02 g / l , calcium chloride 6.24 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20115
∙ MENVEO;
∙ meningococcal group a oligosaccharide 10 mcg / 0.5 ml , meningococcal group c oligosaccharide 5 mcg / 0.5 ml , meningococcal group w-135 oligosaccharide 5 mcg / 0.5 ml , meningococcal group y oligosaccharide 5 mcg / 0.5 ml , corynebacterium diphtheriae crm-197 protein 47 mcg / 0.5 ml;
∙ 2010-07-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intramuscular | Intramusculaire;
∙ Solution , Powder For Solution | Solution , Poudre Pour Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02347393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83276
∙ NIMENRIX;
∙ meningococcal polysaccharide antigen group a 5 mcg / 0.5 ml , meningococcal polysaccharide antigen group c 5 mcg / 0.5 ml , meningococcal polysaccharide antigen group w-135 5 mcg / 0.5 ml , meningococcal polysaccharide antigen group y 5 mcg / 0.5 ml , tetanus toxoid 44 mcg / 0.5 ml;
∙ 2013-08-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intramuscular | Intramusculaire;
∙ Kit , Powder For Solution | Trousse , Poudre Pour Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02402904
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88773
∙ PERIOLIMEL 2.5% E;
∙ methionine 1.26 g / l , l-phenylalanine 1.76 g / l , l-proline 1.51 g / l , serine 1.0 g / l , l-threonine 1.26 g / l , tryptophan 0.42 g / l , lysine (l-lysine acetate) 1.99 g / l , alanine 3.66 g / l , l-arginine 2.48 g / l , l-aspartic acid 0.73 g / l , glutamic acid 1.26 g / l , glycine 1.76 g / l , histidine 1.51 g / l , l-isoleucine 1.26 g / l , l-leucine 1.76 g / l , olive oil 24 g / l , soybean oil 6 g / l , l-tyrosine 0.06 g / l , l-valine 1.62 g / l , sodium acetate trihydrate 1.16 g / l , sodium glycerophosphate 1.91 g / l , potassium chloride 1.19 g / l , magnesium chloride 0.45 g / l , calcium chloride 0.30 g / l , dextrose 82.50 g / l;
∙ 2011-02-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 25.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02352494
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83774
∙ OLIMEL 4.4% E;
∙ methionine 2.21 g / l , l-phenylalanine 3.07 g / l , l-proline 2.64 g / l , serine 1.75 g / l , l-threonine 2.21 g / l , tryptophan 0.74 g / l , lysine (l-lysine acetate) 3.48 g / l , alanine 6.41 g / l , l-arginine 4.34 g / l , l-aspartic acid 1.28 g / l , glutamic acid 2.21 g / l , glycine 3.07 g / l , histidine 2.64 g / l , l-isoleucine 2.21 g / l , l-leucine 3.07 g / l , olive oil 32 g / l , soybean oil 8 g / l , l-tyrosine 0.11 g / l , l-valine 2.83 g / l , sodium acetate trihydrate 1.50 g / l , sodium glycerophosphate 3.67 g / l , potassium chloride 2.24 g / l , magnesium chloride 0.81 g / l , calcium chloride 0.52 g / l , dextrose 154 g / l;
∙ 2011-02-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 25.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02352516
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83777
∙ OLIMEL 5.7% E;
∙ methionine 2.84 g / l , l-phenylalanine 3.95 g / l , l-proline 3.40 g / l , serine 2.25 g / l , l-threonine 2.84 g / l , tryptophan 0.95 g / l , lysine (l-lysine acetate) 4.48 g / l , alanine 8.24 g / l , l-arginine 5.58 g / l , l-aspartic acid 1.65 g / l , glutamic acid 2.84 g / l , glycine 3.95 g / l , histidine 3.40 g / l , l-isoleucine 2.84 g / l , l-leucine 3.95 g / l , olive oil 32 g / l , soybean oil 8 g / l , l-tyrosine 0.15 g / l , l-valine 3.64 g / l , sodium acetate trihydrate 1.50 g / l , sodium glycerophosphate 3.67 g / l , potassium chloride 2.24 g / l , magnesium chloride 0.81 g / l , calcium chloride 0.52 g / l , dextrose 121 g / l;
∙ 2011-01-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 25.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02352532
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83779
∙ CLINIMIX E;
∙ methionine 200 mg / 100 ml , l-isoleucine 300 mg / 100 ml , l-valine 290 mg / 100 ml , histidine 240 mg / 100 ml , l-threonine 210 mg / 100 ml , magnesium chloride 24 mg / 100 ml , dextrose 10 g / 100 ml , l-leucine 365 mg / 100 ml , l-phenylalanine 280 mg / 100 ml , lysine (l-lysine hydrochloride) 290 mg / 100 ml , tryptophan 90 mg / 100 ml , l-alanine 1.04 g / 100 ml , l-arginine 575 mg / 100 ml , l-proline 340 mg / 100 ml , serine 250 mg / 100 ml , glycine 515 mg / 100 ml , l-tyrosine 20 mg / 100 ml , sodium acetate 205 mg / 100 ml , potassium phosphate dibasic 261 mg / 100 ml , sodium chloride 58.5 mg / 100 ml;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 20.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02142384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20291
∙ CLINIMIX;
∙ methionine 200 mg / 100 ml , l-isoleucine 300 mg / 100 ml , l-valine 290 mg / 100 ml , histidine 240 mg / 100 ml , l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-alanine 1.04 g / 100 ml , l-arginine 575 mg / 100 ml , l-proline 340 mg / 100 ml , serine 250 mg / 100 ml , glycine 515 mg / 100 ml , l-tyrosine 20 mg / 100 ml , dextrose 16.6 g / 100 ml , l-leucine 365 mg / 100 ml , l-phenylalanine 280 mg / 100 ml , lysine (l-lysine hydrochloride) 290 mg / 100 ml;
∙ 1996-07-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 16.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02142260
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20278
∙ CLINIMIX E;
∙ methionine 200 mg / 100 ml , l-isoleucine 300 mg / 100 ml , l-valine 290 mg / 100 ml , histidine 240 mg / 100 ml , l-threonine 210 mg / 100 ml , tryptophan 90 mg / 100 ml , l-alanine 1.04 g / 100 ml , l-arginine 575 mg / 100 ml , l-proline 340 mg / 100 ml , serine 250 mg / 100 ml , glycine 515 mg / 100 ml , l-tyrosine 20 mg / 100 ml , sodium acetate 205 mg / 100 ml , potassium phosphate dibasic 261 mg / 100 ml , sodium chloride 58.5 mg / 100 ml , magnesium chloride 24 mg / 100 ml , dextrose 16.6 g / 100 ml , l-leucine 365 mg / 100 ml , l-phenylalanine 280 mg / 100 ml , lysine (l-lysine hydrochloride) 290 mg / 100 ml;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 20.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02142376
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20290
∙ OLIMEL 7.6% E;
∙ methionine 3.79 g / l , l-phenylalanine 5.26 g / l , l-proline 4.53 g / l , serine 3 g / l , l-threonine 3.79 g / l , tryptophan 1.26 g / l , lysine (l-lysine acetate) 5.97 g / l , alanine 10.99 g / l , l-arginine 7.44 g / l , l-aspartic acid 2.2 g / l , glutamic acid 3.79 g / l , glycine 5.26 g / l , histidine 4.53 g / l , l-isoleucine 3.79 g / l , l-leucine 5.26 g / l , olive oil 28 g / l , soybean oil 7 g / l , l-tyrosine 0.2 g / l , l-valine 4.86 g / l , sodium acetate trihydrate 1.5 g / l , sodium glycerophosphate 3.67 g / l , potassium chloride 2.24 g / l , magnesium chloride 0.81 g / l , calcium chloride 0.52 g / l , dextrose 80.67 g / l;
∙ 2018-10-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 25.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02477955
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96874
∙ TRI-CIRA LO 21;
∙ norgestimate 0.18 mg , ethinyl estradiol 0.025 mg , norgestimate 0.215 mg , ethinyl estradiol 0.025 mg , norgestimate 0.25 mg , ethinyl estradiol 0.025 mg;
∙ 2014-06-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02401967
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88684
∙ TRI-CIRA LO 28;
∙ norgestimate 0.18 mg , ethinyl estradiol 0.025 mg , norgestimate 0.215 mg , ethinyl estradiol 0.025 mg , norgestimate 0.25 mg , ethinyl estradiol 0.025 mg;
∙ 2014-06-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02401975
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88685
∙ TRI-CIRA 21;
∙ norgestimate 0.18 mg , ethinyl estradiol 0.035 mg , norgestimate 0.215 mg , ethinyl estradiol 0.035 mg , norgestimate 0.25 mg , ethinyl estradiol 0.035 mg;
∙ 2021-03-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02508087
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99744
∙ TRI-CIRA 28;
∙ norgestimate 0.18 mg , ethinyl estradiol 0.035 mg , norgestimate 0.215 mg , ethinyl estradiol 0.035 mg , norgestimate 0.25 mg , ethinyl estradiol 0.035 mg;
∙ 2021-03-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Tablet | Comprimé;
∙ 68:12.00 – CONTRACEPTIVES;
∙ Prescription | Prescription;
∙ APOTEX INC;
∙ DIN: 02508095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99745
∙ ARTISTRY IDEAL RADIANCE ILLUMINATING CC CREAM;
∙ octinoxate 5.5 % / w/w , oxybenzone 0.5 % / w/w , titanium dioxide 0.84 % / w/w , zinc oxide 9.8 % / w/w , ensulizole 2 % / w/w;
∙ 2015-05-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ AMWAY CORP.;
∙ DIN: 02434873
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91917
∙ NIVEA SUN;
∙ octinoxate 6.75 % / w/w , oxybenzone 5.40 % / w/w , octisalate 4.50 % / w/w , avobenzone 2.85 % / w/w , octocrylene 2.00 % / w/w;
∙ 2015-01-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Stick | Bâton;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BEIERSDORF CANADA INC;
∙ DIN: 02416972
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90160
∙ BLISTEX DCT;
∙ octinoxate 7.3 % , oxybenzone 4.5 % , menthol 0.6 % , phenol 0.48 % , camphor 0.38 %;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 02157292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42607
∙ ESSENTIAL ENERGY DAY CREAM;
∙ octinoxate 7.4 % , homosalate 5 % , octocrylene 3 % , avobenzone 2 % , oxybenzone 1.5 %;
∙ 2018-02-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02465590
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95382
∙ BENEFIANCE WRINKLE SMOOTHING DAY CREAM;
∙ octinoxate 7.4 % , homosalate 5 % , octocrylene 3 % , avobenzone 2 % , oxybenzone 1.5 %;
∙ 2019-01-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ SHISEIDO AMERICAS CORPORATION DIST;
∙ DIN: 02479028
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96973
∙ BLISTEX ULTRA LIP BALM;
∙ octinoxate 7.4 % , oxybenzone 5.2 % , octisalate 5 % , meradimate 4.8 % , homosalate 4.5 % , dimethicone 3 %;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 02051524
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42310
∙ PERFECTING DAY CREAM BROAD SPECTRUM SPF 30 PA +++;
∙ octinoxate 7.5 % , oxybenzone 4.0 % , homosalate 6.5 % , octisalate 5.0 % , avobenzone 2.0 %;
∙ 2008-02-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MURAD LLC;
∙ DIN: 02290677
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77611
∙ ESSENTIAL-C DAY MOISTURE BROAD SPECTRUM SPF 30 PA+++;
∙ octinoxate 7.5 % / w/w , homosalate 6.5 % / w/w , octisalate 5.0 % / w/w , avobenzone 3.0 % / w/w , oxybenzone 2.0 % / w/w;
∙ 2014-04-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MURAD LLC;
∙ DIN: 02407205
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89192
∙ LIQUID SPRAY SUNSCREEN;
∙ octinoxate 7.5 % / w/w , octisalate 4.0 % / w/w , oxybenzone 4.0 % / w/w , avobenzone 2.0 % / w/w , octocrylene 1.5 % / w/w;
∙ 2014-05-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CROC BLOC PRODUCTS INC.;
∙ DIN: 02419815
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90444
∙ DAY MOISTURIZER BROAD SPECTRUM SPF 30 WITH SKIN FIRMING RETINOL;
∙ octinoxate 7.5 % / w/w , octisalate 5 % / w/w , oxybenzone 4 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w;
∙ 2019-07-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ STRIVECTIN OPERATING COMPANY INC;
∙ DIN: 02482355
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97281
∙ CERAMIDE PREMIERE INTENSE MOISTURE AND RENEWAL ACTIVATION CREAM SPF 30;
∙ octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , oxybenzone 4.0 % / w/w , octocrylene 3.0 % / w/w , avobenzone 2.0 % / w/w;
∙ 2012-01-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELIZABETH ARDEN (CANADA) LIMITED;
∙ DIN: 02371847
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85697
∙ PREVAGE ANTI-AGING MOISTURE LOTION SPF 30;
∙ octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , oxybenzone 5.0 % / w/w , octocrylene 2.2 % / w/w , avobenzone 2.0 % / w/w;
∙ 2009-10-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELIZABETH ARDEN (CANADA) LIMITED;
∙ DIN: 02326426
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81175
∙ PREVAGE ANTI-AGING MOISTURE CREAM SPF 30;
∙ octinoxate 7.5 % / w/w , octisalate 5.0 % / w/w , oxybenzone 5.0 % / w/w , octocrylene 2.2 % / w/w , avobenzone 2.0 % / w/w;
∙ 2011-09-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ELIZABETH ARDEN (CANADA) LIMITED;
∙ DIN: 02366169
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85102
∙ CETAPHIL DAILY FACIAL MOISTURIZER (SPF 50);
∙ octinoxate 7.5 % / w/w , octocrylene 7.0 % / w/w , oxybenzone 6.0 % / w/w , titanium dioxide 5.7 % / w/w , octisalate 5.0 % / w/w;
∙ 2009-01-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ GALDERMA CANADA INC;
∙ DIN: 02315831
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80135
∙ ORIGINS GINZING SPF 40 ENERGY-BOOSTING TINTED MOISTURIZER;
∙ octinoxate 7.5 % / w/w , titanium dioxide 3 % / w/w , zinc oxide 3 % / w/w , octocrylene 2 % / w/w , octisalate 2 % / w/w;
∙ 2017-06-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ ORIGINS NATURAL RESOURCES DIST;
∙ DIN: 02457571
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94463
∙ SUNSCREEN LOTION ECRAN SOLAIRE SPF/FPS 30;
∙ octisalate 5 % / w/w , avobenzone 2 % / w/w , homosalate 13 % / w/w , octocrylene 2 % / w/w , oxybenzone 4 % / w/w;
∙ 2016-03-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447657
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93323
∙ DRY BALANCE SUNSCREEN SPRAY SPF 50+;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 10 % / w/w , oxybenzone 4 % / w/w , octocrylene 3 % / w/w;
∙ 2017-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02456036
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94288
∙ FACE & BODY SUNSCREEN BROAD SPECTRUM SPF 30;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 5 % / w/w , octocrylene 2.7 % / w/w , oxybenzone 5 % / w/w;
∙ 2016-04-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ HERBALIFE OF CANADA LIMITED;
∙ DIN: 02438216
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92258
∙ SUNSCREEN LOTION ECRAN SOLAIRE SPF/FPS 50+;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 10 % / w/w , oxybenzone 6 % / w/w , homosalate 15 % / w/w;
∙ 2016-02-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447665
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93324
∙ CLINIQUE SPF 50 FACE CREAM;
∙ octisalate 5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.7 % / w/w , homosalate 5 % / w/w , oxybenzone 5 % / w/w;
∙ 2009-02-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ CLINIQUE LABORATORIES DIST;
∙ DIN: 02316498
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80199
∙ FACE AND BODY LOTION SPF 50;
∙ octisalate 5 % / w/w , drometrizole trisiloxane 4.5 % / w/w , titanium dioxide 5.85 % / w/w , avobenzone 3 % / w/w , octocrylene 2.5 % / w/w , terephthalylidene dicamphor sulfonic acid 1.5 % / w/w;
∙ 2009-05-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02318857
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80435
∙ BANANA BOAT SUNCOMFORT SUNSCREEN SPRAY SPF 50+;
∙ octisalate 5 % / w/w , homosalate 10 % / w/w , oxybenzone 4 % / w/w , avobenzone 3 % / w/w , octocrylene 3 % / w/w;
∙ 2015-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Aerosol | Aérosol;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02426714
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91128
∙ MOISTURE OIL-FREE SPF 30;
∙ octisalate 5.0 % / w/w , octocrylene 2.35 % / w/w , avobenzone 3.0 % / w/w , homosalate 12.0 % / w/w , oxybenzone 6.0 % / w/w;
∙ 2010-07-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02345595
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83101
∙ KIDS SUNSCREEN CONTINUOUS SPRAY;
∙ octocrylene 10 % , avobenzone 3 % , homosalate 15 % , octisalate 5 % , oxybenzone 6 %;
∙ 2016-03-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray, Bag-On-Valve | Pulvérisation, Sac-Sur-Valve;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ FRUIT OF THE EARTH, INC;
∙ DIN: 02447533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93312
∙ ULTRA SHEER DRY-TOUCH SUNSCREEN SPF 110;
∙ octocrylene 10 % / w/w , homosalate 15 % / w/w , oxybenzone 6 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2010-05-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ JOHNSON & JOHNSON INC;
∙ DIN: 02325292
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81069
∙ BROAD SPECTRUM SPF FPS 50;
∙ octocrylene 10 % / w/w , octinoxate 7.5 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2017-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ WILC HEALTHCARE INC;
∙ DIN: 02421542
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90618
∙ SPF 50 BROAD SPECTRUM KIDS;
∙ octocrylene 10 % / w/w , octinoxate 7.5 % / w/w , homosalate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w;
∙ 2018-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BU BRANDS, LLC;
∙ DIN: 02462125
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94986
∙ SPF/FPS 50 BROAD SPECTRUM ALCOHOL FREE SUNSCREEN;
∙ octocrylene 10 % / w/w , octinoxate 7.5 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , homosalate 7.5 % / w/w;
∙ 2018-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ BU BRANDS, LLC;
∙ DIN: 02462176
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94990
∙ OMBRELLE CREAM SPF 60;
∙ octocrylene 10.00 % , titanium dioxide 4.15 % , avobenzone 3.50 % , drometrizole trisiloxane 3.00 % , terephthalylidene dicamphor sulfonic acid 3.00 %;
∙ 2007-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02280353
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76603
∙ SPF 50+ KIDS (80 MINUTES) WATER RESISTANT;
∙ octocrylene 3 % / w/w , homosalate 15 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w , octisalate 5 % / w/w;
∙ 2019-09-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02464322
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95248
∙ HIGH PERFORMANCE SUNSCREEN SPRAY SPF 50;
∙ octocrylene 3 % / w/w , oxybenzone 4 % / w/w , avobenzone 3 % / w/w , homosalate 10 % / w/w , octisalate 5 % / w/w;
∙ 2019-01-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Spray | Pulvérisation;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ EDGEWELL PERSONAL CARE CANADA, ULC;
∙ DIN: 02475642
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96599
∙ ULTRA-LIGHT LOTION SPF 50;
∙ octocrylene 5.00 % / w/w , octisalate 5.00 % / w/w , avobenzone 3.00 % / w/w , oxybenzone 6.00 % / w/w , terephthalylidene dicamphor sulfonic acid 2.00 % / w/w , homosalate 10.00 % / w/w;
∙ 2011-06-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02364735
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84962
∙ AQUAGEL DEFENSE 50;
∙ octocrylene 6 % / w/w , oxybenzone 3.86 % / w/w , octisalate 3.21 % / w/w , avobenzone 3 % / w/w , homosalate 10.72 % / w/w;
∙ 2019-11-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Gel | Gel;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LANCOME CANADA;
∙ DIN: 02491095
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98111
∙ ANTHELIOS XL MELT-IN CREAM;
∙ octocrylene 7 % / w/w , bemotrizinol 5 % / w/w , octisalate 5 % / w/w , avobenzone 4 % / w/w , drometrizole trisiloxane 3 % / w/w , titanium dioxide 2.5 % / w/w , terephthalylidene dicamphor sulfonic acid 0.5 % / w/w;
∙ 2019-06-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02472007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96124
∙ COMPLETE* DRY TOUCH SUNSCREEN/ÉCRAN SOLAIRE;
∙ octocrylene 7 % / w/w , homosalate 7 % / w/w , octisalate 5 % / w/w , avobenzone 3 % / w/w , drometrizole trisiloxane 0.5 % / w/w;
∙ 2019-02-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02461048
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94854
∙ SUN PROTECTION CREAM SPF 30;
∙ octocrylene 7.0 % , titanium dioxide 4.15 % , avobenzone 3.00 % , drometrizole trisiloxane 2.5 % , terephthalylidene dicamphor sulfonic acid 0.5 %;
∙ 2008-04-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02302810
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78813
∙ AQUA SOLEIL CRÈME VISAGE ET CORPS FPS 35;
∙ octocrylene 8 % , octisalate 5 % , ensulizole 3 % , zinc oxide 7 % , titanium dioxide 1.5 %;
∙ 2018-09-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OCCY LABORATOIRE INC.;
∙ DIN: 02402750
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88759
∙ ULTRA-FLUID SUN PROTECTION SPF 30;
∙ octocrylene 8 % , titanium dioxide 4 % , avobenzone 3 % , drometrizole trisiloxane 2 % , terephthalylidene dicamphor sulfonic acid 1 %;
∙ 2008-04-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ VICHY CANADA;
∙ DIN: 02289393
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77476
∙ EMULSION SPF 50+;
∙ octocrylene 9 % / w/w , bisoctrizole 4 % / w/w , titanium dioxide 3.4 % / w/w , avobenzone 3 % / w/w , bemotrizinol 2 % / w/w;
∙ 2016-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PIERRE FABRE DERMO-COSMETIQUE CANADA INC;
∙ DIN: 02446545
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93191
∙ KIDS SPRAY;
∙ octocrylene 9 % / w/w , bisoctrizole 4 % / w/w , titanium dioxide 3.4 % / w/w , avobenzone 3 % / w/w , bemotrizinol 2 % / w/w;
∙ 2016-03-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Emulsion | Émulsion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ PIERRE FABRE DERMO-COSMETIQUE CANADA INC;
∙ DIN: 02446553
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93192
∙ SPF 30 SPORT ENDURANCE;
∙ oxybenzone 2.88 % / w/w , octisalate 2.4 % / w/w , avobenzone 2.24 % / w/w , drometrizole trisiloxane 0.5 % / w/w , homosalate 8 % / w/w , octocrylene 4.48 % / w/w;
∙ 2016-02-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02447770
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93336
∙ DORMER 211 SPF 30;
∙ oxybenzone 3 % , avobenzone 2.5 % , octinoxate 7.5 % , octisalate 5 % , titanium dioxide 0.8 %;
∙ 2002-06-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ DORMER LABORATORIES INC.;
∙ DIN: 02242226
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65907
∙ MKMEN ADVANCED FACIAL HYDRATOR SUNSCREEN BROAD SPECTRUM SPF 30;
∙ oxybenzone 4 % / w/w , avobenzone 2 % / w/w , homosalate 5 % / w/w , octocrylene 2 % / w/w , octisalate 5 % / w/w;
∙ 2021-06-29;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ MARY KAY COSMETICS LTD;
∙ DIN: 02507382
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99677
∙ ANEW SKINVINCIBLE DAY LOTION BROAD SPECTRUM SPF 50 SUNSCREEN;
∙ oxybenzone 4.75 % / w/w , avobenzone 2.8 % / w/w , homosalate 9.5 % / w/w , octinoxate 7.5 % / w/w , octocrylene 2.56 % / w/w;
∙ 2016-05-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02443228
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92779
∙ SPF 60 ULTRA LIGHT ADVANCED WEIGHTLESS FACE LOTION;
∙ oxybenzone 6 % / w/w , octisalate 5 % / w/w , homosalate 15 % / w/w , octocrylene 5 % / w/w , avobenzone 3 % / w/w;
∙ 2013-02-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ OMBRELLE CANADA;
∙ DIN: 02395096
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88022
∙ LIP CONDITIONER LIP BALM;
∙ padimate o 6.6 % , meradimate 2.5 % , menthol 0.6 % , camphor 0.38 % , phenol 0.45 %;
∙ 1980-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Ointment | Pommade;
∙ 84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
∙ Otc | En Vente Libre;
∙ BLISTEX CORPORATION;
∙ DIN: 01977717
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42334
∙ PEDIACEL;
∙ pertactin 3 mcg / 0.5 ml , pertussis toxoid 20 mcg / 0.5 ml , diphtheria toxoid 15 lf / 0.5 ml , tetanus toxoid 5 lf / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney 40 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1 8 unit / 0.5 ml , inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett 32 unit / 0.5 ml , haemophilus influenzae type b-prp 10 mcg / 0.5 ml , tetanus protein 30 mcg / 0.5 ml , filamentous haemagglutinin 20 mcg / 0.5 ml , fimbriae 5 mcg / 0.5 ml;
∙ 2007-10-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 11.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ SANOFI PASTEUR LIMITED;
∙ DIN: 02243167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67042
∙ TRAVASOL;
∙ phenylalanine 560 mg / 100 ml , methionine 400 mg / 100 ml , l-lysine (l-lysine hydrochloride) 580 mg / 100 ml , isoleucine 600 mg / 100 ml , valine 580 mg / 100 ml , histidine 480 mg / 100 ml , threonine 420 mg / 100 ml , tryptophan 180 mg / 100 ml , l-alanine 2.07 g / 100 ml , glycine 1.03 g / 100 ml , arginine 1.15 g / 100 ml , proline 680 mg / 100 ml , tyrosine 40 mg / 100 ml , serine 500 mg / 100 ml , leucine 730 mg / 100 ml;
∙ 1991-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 15.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00872296
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11329
∙ PREVNAR 13;
∙ pneumococcal polysaccharide serotype 1 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6a 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 4.4 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 2.2 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 2.2 mcg / 0.5 ml , corynebacterium diphtheriae crm-197 protein 34 mcg / 0.5 ml;
∙ 2010-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 14.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ PFIZER CANADA ULC;
∙ DIN: 02335204
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82074
∙ PNEUMOVAX 23;
∙ pneumococcal polysaccharide serotype 1 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 2 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 8 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9n 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 10a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 11a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 12f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 15b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 17f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 20 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 22f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 33f 25 mcg / 0.5 ml;
∙ 1978-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 23.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Solution | Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 00431648
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2969
∙ PNEUMOVAX 23;
∙ pneumococcal polysaccharide serotype 1 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 2 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 3 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 4 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 8 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9n 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 10a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 11a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 12f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 15b 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 17f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 18c 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19a 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 19f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 20 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 22f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f 25 mcg / 0.5 ml , pneumococcal polysaccharide serotype 33f 25 mcg / 0.5 ml;
∙ 2021-04-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 23.00;
∙ Intramuscular , Subcutaneous | Intramusculaire , Sous-Cutanée;
∙ Solution | Solution;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 02436442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92078
∙ SYNFLORIX;
∙ pneumococcal polysaccharide serotype 4 conjugated to protein d carrier protein 3 mcg / 0.5 ml , pneumococcal polysaccharide serotype 5 conjugated to protein d carrier protein 1 mcg / 0.5 ml , pneumococcal polysaccharide serotype 6b conjugated to protein d carrier protein 1 mcg / 0.5 ml , pneumococcal polysaccharide serotype 7f conjugated to protein d carrier protein 1 mcg / 0.5 ml , pneumococcal polysaccharide serotype 9v conjugated to protein d carrier protein 1 mcg / 0.5 ml , pneumococcal polysaccharide serotype 14 conjugated to protein d carrier protein 1 mcg / 0.5 ml , pneumococcal polysacc. serot. 18c conjug. to tetanus toxoid carrier prot. 3 mcg / 0.5 ml , pneumococcal polysaccharid serot. 19f conjug. to diphtheria toxoid carrier prot. 3 mcg / 0.5 ml , pneumococcal polysaccharide serotype 23f conjugated to protein d carrier protein 1 mcg / 0.5 ml , pneumococcal polysaccharide serotype 1 conjugated to protein d carrier protein 1 mcg / 0.5 ml;
∙ 2009-05-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 10.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ GLAXOSMITHKLINE INC;
∙ DIN: 02320541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80596
∙ MOVIPREP;
∙ polyethylene glycol 3350 100 g / sachet , sodium sulfate anhydrous 7.5 g / sachet , sodium chloride 2.691 g / sachet , potassium chloride 1.015 g / sachet , sodium ascorbate 5.9 g / sachet , ascorbic acid 4.7 g / sachet;
∙ 2011-04-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Ethical | Spécialité Médicale;
∙ ARALEZ PHARMACEUTICALS CANADA INC;
∙ DIN: 02359499
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84451
∙ COLYTE;
∙ polyethylene glycol 3350 857.69 mg / g , sodium chloride 20.87 mg / g , potassium chloride 10.65 mg / g , sodium bicarbonate 24.02 mg / g , sodium sulfate 81.2 mg / g;
∙ 1986-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Nasogastric , Oral | Nasogastrique , Orale;
∙ Powder For Solution | Poudre Pour Solution;
∙ 56:12.00 – CATHARTICS AND LAXATIVES;
∙ Ethical | Spécialité Médicale;
∙ PENDOPHARM DIVISION OF PHARMASCIENCE INC;
∙ DIN: 00677442
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6616
∙ NORMOSOL-R;
∙ potassium chloride 0.037 g / 100 ml , magnesium chloride (magnesium chloride hexahydrate) 0.014 g / 100 ml , sodium chloride 0.526 g / 100 ml , sodium acetate 0.222 g / 100 ml , sodium gluconate 0.502 g / 100 ml;
∙ 1965-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ ICU MEDICAL CANADA INC;
∙ DIN: 00039500
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1738
∙ NATURALYTE H-408;
∙ potassium chloride 10.06 g / l , calcium chloride 9.92 g / l , sodium chloride 263 g / l , magnesium chloride 6.86 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327538
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81284
∙ NATURALYTE H-617;
∙ potassium chloride 10.06 g / l , sodium chloride 263 g / l , calcium chloride 8.27 g / l , magnesium chloride 3.43 g / l , acetic acid 10.81 g / l , dextrose 98.99 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02326922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81225
∙ CITRASATE C3125;
∙ potassium chloride 10.1 g / l , sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2011-07-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02366576
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85142
∙ HEMOSATE ULTRA HS3125;
∙ potassium chloride 10.1 g / l , sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2020-02-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02413914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89856
∙ CITRASATE C3150;
∙ potassium chloride 10.1 g / l , sodium chloride 263 g / l , calcium chloride 7.47 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2013-02-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02366614
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85146
∙ ACID CONCENTRATE 2156;
∙ potassium chloride 10.1 g / l , sodium chloride 268 g / l , calcium chloride 6.24 g / l , magnesium chloride 3.21 g / l , acetic acid 8.11 g / l , dextrose 90 g / l;
∙ 1999-01-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02239491
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62965
∙ CITRASATE C4125;
∙ potassium chloride 13.47 g / l , sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2013-03-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02366584
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85143
∙ HEMOSATE ULTRA HS4125;
∙ potassium chloride 13.47 g / l , sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2020-03-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02413922
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89857
∙ SELECTBAG ONE (AX125G);
∙ potassium chloride 14.9 g / l , calcium chloride 36.8 g / l , magnesium chloride 20.3 g / l , acetic acid 36.0 g / l , dextrose 220.0 g / l;
∙ 2016-09-07;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02414813
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89944
∙ SELECTBAG ONE (AX150G);
∙ potassium chloride 14.9 g / l , calcium chloride 44.1 g / l , magnesium chloride 20.3 g / l , acetic acid 36.0 g / l , dextrose 220.0 g / l;
∙ 2016-02-19;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02414821
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89945
∙ CITRASATE C1125;
∙ potassium chloride 3.35 g / l , sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2011-07-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02366541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85140
∙ HEMOSATE ULTRA HS1125;
∙ potassium chloride 3.35 g / l , sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2020-03-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02413892
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89853
∙ NATURALYTE H-225;
∙ potassium chloride 3.36 g / l , calcium chloride 8.27 g / l , sodium chloride 263 g / l , magnesium chloride 4.57 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327465
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81279
∙ NATURALYTE H-201;
∙ potassium chloride 3.36 g / l , sodium chloride 263 g / l , calcium chloride 9.92 g / l , magnesium chloride 3.43 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330024
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81578
∙ LACTATED RINGER’S AND 5% INJECTION, USP;
∙ potassium chloride 30 mg / 100 ml , calcium chloride 20 mg / 100 ml , dextrose 5 g / 100 ml , sodium chloride 600 mg / 100 ml , sodium lactate 310 mg / 100 ml;
∙ 1973-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00061131
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1673
∙ NATURALYTE H-410;
∙ potassium chloride 6.71 g / l , calcium chloride 6.61 g / l , sodium chloride 263 g / l , magnesium chloride 4.57 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327511
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81283
∙ CITRASATE C2125;
∙ potassium chloride 6.71 g / l , sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2011-07-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02366568
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85141
∙ HEMOSATE ULTRA HS2125;
∙ potassium chloride 6.71 g / l , sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2020-02-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02413906
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89855
∙ HEMOSATE ULTRA HS2150;
∙ potassium chloride 6.71 g / l , sodium chloride 263 g / l , calcium chloride 7.47 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l , sodium acetate 1.11 g / l;
∙ 2020-03-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02413957
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89860
∙ NATURALYTE H-320;
∙ potassium chloride 6.71 g / l , sodium chloride 289.3 g / l , calcium chloride 8.27 g / l , magnesium chloride 4.57 g / l , acetic acid 8.1 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330229
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81598
∙ NATURALYTE H-260;
∙ potassium chloride 6.71 g / l , sodium chloride 289.3 g / l , calcium chloride 9.92 g / l , magnesium chloride 4.57 g / l , acetic acid 8.1 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327384
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81270
∙ ISOLYTE S PH 7.4 (MULTI-ELECTROLYTE INJECTION);
∙ potassium phosphate monobasic 820 mcg / 100 ml , sodium chloride 530 mg / 100 ml , sodium gluconate 500 mg / 100 ml , sodium acetate 370 mg / 100 ml , potassium chloride 37 mg / 100 ml , magnesium chloride 30 mg / 100 ml , sodium phosphate dibasic 12 mg / 100 ml;
∙ 1996-09-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 01931679
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=21757
∙ SINUS RELIEF;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg;
∙ 2012-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02368196
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85317
∙ SINUS MEDICATION DAY & NIGHT;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , doxylamine succinate 6.25 mg;
∙ 2012-05-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02383608
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86935
∙ COLD AND SINUS RELIEF COMBO;
∙ pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , doxylamine succinate 6.25 mg;
∙ 2013-06-24;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 28:08.92 – MISCELLANEOUS ANALGESICS AND ANTIPYRETICS , 04:04.04 – ETHANOLAMINE DERIVATIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02388537
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87406
∙ FLU RELIEF;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , diphenhydramine hydrochloride 25 mg;
∙ 2012-08-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02383357
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86911
∙ COLD MEDICATION;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg , chlorpheniramine maleate 2 mg;
∙ 2012-06-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02383373
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86913
∙ COMPLETE;
∙ pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg , pseudoephedrine hydrochloride 30 mg , dextromethorphan hydrobromide 15 mg , acetaminophen 500 mg , chlorpheniramine maleate 2 mg;
∙ 2015-05-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02427559
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91207
∙ TOTAL COLD & FLU COMBO;
∙ pseudoephedrine hydrochloride 30 mg , diphenhydramine hydrochloride 25 mg , pseudoephedrine hydrochloride 30 mg , acetaminophen 500 mg , dextromethorphan hydrobromide 15 mg , guaifenesin 100 mg , acetaminophen 500 mg;
∙ 2013-07-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02384175
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86992
∙ COUGH, COLD & FLU;
∙ pseudoephedrine hydrochloride 60 mg , dextromethorphan hydrobromide 30 mg , acetaminophen 650 mg , pseudoephedrine hydrochloride 60 mg , acetaminophen 650 mg , diphenhydramine hydrochloride 50 mg;
∙ 2012-09-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Oral | Orale;
∙ Kit , Tablet | Trousse , Comprimé;
∙ 48:08.00 – ANTITUSSIVES;
∙ Otc | En Vente Libre;
∙ VITA HEALTH PRODUCTS INC;
∙ DIN: 02385244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87088
∙ GARDASIL 9;
∙ recombinant human papillomavirus type 6 l1 protein 30 mcg / 0.5 ml , recombinant human papillomavirus type 11 l1 protein 40 mcg / 0.5 ml , recombinant human papillomavirus type 16 l1 protein 60 mcg / 0.5 ml , recombinant human papillomavirus type 18 l1 protein 40 mcg / 0.5 ml , recombinant human papillomavirus type 31 l1 protein 20 mcg / 0.5 ml , recombinant human papillomavirus type 33 l1 protein 20 mcg / 0.5 ml , recombinant human papillomavirus type 45 l1 protein 20 mcg / 0.5 ml , recombinant human papillomavirus type 52 l1 protein 20 mcg / 0.5 ml , recombinant human papillomavirus type 58 l1 protein 20 mcg / 0.5 ml;
∙ 2015-03-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 9.00;
∙ Intramuscular | Intramusculaire;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ MERCK CANADA INC;
∙ DIN: 02437058
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92136
∙ CITRASATE C2150;
∙ sodium acetate 1.11 g / l , potassium chloride 6.71 g / l , sodium chloride 263 g / l , calcium chloride 7.47 g / l , magnesium chloride 2.14 g / l , dextrose 49.5 g / l , citric acid 6.91 g / l;
∙ 2013-02-21;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02366606
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85145
∙ H.E.L.P.BICEL;
∙ sodium bicarbonate 3.59 g / l , sodium chloride 6.18 g / l , sodium chloride 4.21 g / l , potassium chloride 2.68 g / l , calcium chloride 2.45 g / l , magnesium chloride 1.83 g / l , dextrose 9.90 g / l;
∙ 2012-03-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN AVITUM AG;
∙ DIN: 02373793
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85901
∙ BSS PLUS;
∙ sodium chloride 0.714 % , potassium chloride 0.038 % , calcium chloride 0.0154 % , magnesium chloride 0.02 % , sodium phosphate dibasic 0.042 % , sodium bicarbonate 0.21 % , dextrose 0.092 % , glutathione disulfide 0.0184 %;
∙ 1982-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 8.00;
∙ Intraocular | Intraoculaire;
∙ Solution , Kit | Solution , Trousse;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Ethical | Spécialité Médicale;
∙ ALCON CANADA INC;
∙ DIN: 00568082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4913
∙ NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-301);
∙ sodium chloride 116.6 g / l , sodium lactate 176.5 g / l , calcium chloride 4.63 g / l , magnesium chloride 2.13 g / l , potassium chloride 1.57 g / l , dextrose 23.1 g / l;
∙ 2013-12-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ NXSTAGE MEDICAL INC;
∙ DIN: 02363615
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84860
∙ NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 304);
∙ sodium chloride 116.6 g / l , sodium lactate 176.5 g / l , calcium chloride 4.63 g / l , magnesium chloride 2.13 g / l , potassium chloride 3.14 g / l , dextrose 23.1 g / l;
∙ 2013-11-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ NXSTAGE MEDICAL INC;
∙ DIN: 02363631
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84861
∙ NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-302);
∙ sodium chloride 122.64 g / l , sodium lactate 156.88 g / l , calcium chloride 4.63 g / l , magnesium chloride 2.13 g / l , potassium chloride 1.57 g / l , dextrose 23.1 g / l;
∙ 2013-07-05;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ NXSTAGE MEDICAL INC;
∙ DIN: 02363666
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84863
∙ ACID CONCENTRATE A1274;
∙ sodium chloride 263 g / l , calcium chloride 4.99 g / l , magnesium chloride 2.12 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l , potassium chloride 3.35 g / l;
∙ 2018-10-01;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02272555
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75807
∙ ACID CONCENTRATE A1268;
∙ sodium chloride 263 g / l , calcium chloride 5 g / l , magnesium chloride 2.14 g / l , acetic acid 10.81 g / l , dextrose 74.25 g / l , potassium chloride 3.35 g / l;
∙ 2006-03-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02262541
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74793
∙ ACID CONCENTRATE A1275;
∙ sodium chloride 263 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l , potassium chloride 5.03 g / l;
∙ 2015-11-06;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02272563
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75808
∙ ACID CONCENTRATE D12248;
∙ sodium chloride 263 g / l , calcium chloride 7.49 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 90 g / l , potassium chloride 6.7 g / l;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02158329
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18268
∙ NATURALYTE H-208;
∙ sodium chloride 263 g / l , calcium chloride 8.27 g / l , magnesium chloride 3.43 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l , potassium chloride 5.03 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02329980
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81574
∙ NATURALYTE H-702;
∙ sodium chloride 263 g / l , calcium chloride 8.27 g / l , magnesium chloride 3.43 g / l , acetic acid 10.81 g / l , dextrose 74.28 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02326914
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81224
∙ NATURALYTE H-623;
∙ sodium chloride 263 g / l , calcium chloride 8.27 g / l , magnesium chloride 4.57 g / l , acetic acid 10.81 g / l , dextrose 74.28 g / l , potassium chloride 10.06 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330016
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81577
∙ NATURALYTE H-206;
∙ sodium chloride 263 g / l , calcium chloride 9.92 g / l , magnesium chloride 3.43 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l , potassium chloride 10.06 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330199
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81595
∙ NATURALYTE H-608;
∙ sodium chloride 263 g / l , calcium chloride 9.92 g / l , magnesium chloride 3.43 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l , potassium chloride 6.71 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330164
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81592
∙ NATURALYTE H-229;
∙ sodium chloride 263 g / l , calcium chloride 9.92 g / l , magnesium chloride 4.57 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l , potassium chloride 6.71 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02326949
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81227
∙ ACID CONCENTRATE D12293;
∙ sodium chloride 263 g / l , potassium chloride 10 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217554
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20044
∙ ACID CONCENTRATE D12290;
∙ sodium chloride 263 g / l , potassium chloride 10 g / l , calcium chloride 7.48 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 90 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217643
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20041
∙ ACID CONCENTRATE D12207;
∙ sodium chloride 263 g / l , potassium chloride 10.05 g / l , calcium chloride 7.49 g / l , magnesium chloride 2.14 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00890197
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10820
∙ ACID CONCENTRATE A1298;
∙ sodium chloride 263 g / l , potassium chloride 10.06 g / l , calcium chloride 7.49 g / l , magnesium chloride 2.14 g / l , dextrose 49.49 g / l , acetic acid 10.81 g / l;
∙ 2015-12-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02435950
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92029
∙ NATURALYTE H-332;
∙ sodium chloride 263 g / l , potassium chloride 10.06 g / l , calcium chloride 8.27 g / l , magnesium chloride 6.86 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327333
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81265
∙ NATURALYTE H-602;
∙ sodium chloride 263 g / l , potassium chloride 10.06 g / l , calcium chloride 9.92 g / l , magnesium chloride 3.43 g / l , acetic acid 10.81 g / l , dextrose 98.99 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327082
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81240
∙ ACID CONCENTRATE D12201;
∙ sodium chloride 263 g / l , potassium chloride 10.1 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 45.0 g / l;
∙ 1989-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00860565
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9852
∙ ACID CONCENTRATE 2126;
∙ sodium chloride 263 g / l , potassium chloride 13.42 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 90.0 g / l;
∙ 2000-09-08;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02242547
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66299
∙ ACID CONCENTRATE A1296;
∙ sodium chloride 263 g / l , potassium chloride 13.42 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , dextrose 49.49 g / l , acetic acid 10.81 g / l;
∙ 2015-12-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02435918
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92024
∙ ACID CONCENTRATE D12302;
∙ sodium chloride 263 g / l , potassium chloride 3.35 g / l , calcium chloride 4.99 g / l , magnesium chloride 2.14 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217635
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20046
∙ ACID CONCENTRATE D12275;
∙ sodium chloride 263 g / l , potassium chloride 3.35 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02218879
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20114
∙ ACID CONCENTRATE D12300;
∙ sodium chloride 263 g / l , potassium chloride 3.35 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217597
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20111
∙ ACID CONCENTRATE D12262;
∙ sodium chloride 263 g / l , potassium chloride 3.35 g / l , calcium chloride 7.49 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 90 g / l;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02158221
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18202
∙ ACID CONCENTRATE A1297;
∙ sodium chloride 263 g / l , potassium chloride 3.35 g / l , calcium chloride 7.49 g / l , magnesium chloride 2.14 g / l , dextrose 49.49 g / l , acetic acid 10.81 g / l;
∙ 2019-06-26;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02435969
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92030
∙ NATURALYTE H-227;
∙ sodium chloride 263 g / l , potassium chloride 3.36 g / l , calcium chloride 6.61 g / l , magnesium chloride 4.57 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330261
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81602
∙ NATURALYTE H-331;
∙ sodium chloride 263 g / l , potassium chloride 3.36 g / l , calcium chloride 8.27 g / l , magnesium chloride 3.43 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330202
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81596
∙ ACID CONCENTRATE D12265;
∙ sodium chloride 263 g / l , potassium chloride 5.02 g / l , calcium chloride 7.49 g / l , magnesium chloride 2.14 g / l , acetic acid 8.11 g / l , dextrose 45 g / l;
∙ 1995-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02158167
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18199
∙ ACID CONCENTRATE D12305;
∙ sodium chloride 263 g / l , potassium chloride 6.7 g / l , calcium chloride 4.99 g / l , magnesium chloride 2.14 g / l , acetic acid 10.8 g / l , dextrose 67.5 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217600
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20118
∙ ACID CONCENTRATE D12291;
∙ sodium chloride 263 g / l , potassium chloride 6.7 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 90 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20121
∙ ACID CONCENTRATE D12294;
∙ sodium chloride 263 g / l , potassium chloride 6.7 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217619
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20119
∙ ACID CONCENTRATE D12236;
∙ sodium chloride 263 g / l , potassium chloride 6.7 g / l , calcium chloride 6.24 g / l , magnesium chloride 3.21 g / l , acetic acid 10.8 g / l , dextrose 67.5 g / l;
∙ 1996-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02217244
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20040
∙ ACID CONCENTRATE D12272;
∙ sodium chloride 263 g / l , potassium chloride 6.7 g / l , calcium chloride 7.49 g / l , magnesium chloride 2.14 g / l , acetic acid 10.8 g / l , dextrose 45 g / l;
∙ 1996-11-25;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02178125
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=34878
∙ ACID CONCENTRATE 2117;
∙ sodium chloride 263 g / l , potassium chloride 6.71 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.8 g / l , dextrose 67.54 g / l;
∙ 1988-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00774944
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10115
∙ NATURALYTE H-232;
∙ sodium chloride 263 g / l , potassium chloride 6.71 g / l , calcium chloride 8.27 g / l , magnesium chloride 3.43 g / l , dextrose 49.49 g / l , acetic acid 10.8 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330253
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81601
∙ NATURALYTE H-624;
∙ sodium chloride 263 g / l , potassium chloride 6.71 g / l , calcium chloride 8.27 g / l , magnesium chloride 4.57 g / l , acetic acid 10.81 g / l , dextrose 74.28 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330032
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81579
∙ NATURALYTE H-401;
∙ sodium chloride 263 g / l , potassium chloride 6.71 g / l , calcium chloride 8.27 g / l , magnesium chloride 6.86 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327309
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81262
∙ NATURALYTE H-200;
∙ sodium chloride 263 g / l , potassium chloride 6.71 g / l , calcium chloride 9.92 g / l , magnesium chloride 3.43 g / l , acetic acid 10.8 g / l , dextrose 98.99 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02330172
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81593
∙ NATURALYTE H-226;
∙ sodium chloride 263 g / l , potassium chloride 8.39 g / l , calcium chloride 8.27 g / l , magnesium chloride 4.57 g / l , acetic acid 10.8 g / l , dextrose 49.49 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327406
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81272
∙ ACID CONCENTRATE A1266;
∙ sodium chloride 263.0 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , acetic acid 10.81 g / l , dextrose 74.25 g / l , potassium chloride 10.1 g / l;
∙ 2006-04-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02262525
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74791
∙ ACID CONCENTRATE A1267;
∙ sodium chloride 263.0 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , acetic acid 10.81 g / l , dextrose 74.25 g / l , potassium chloride 6.71 g / l;
∙ 2006-05-09;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02262533
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74792
∙ ACID CONCENTRATE A1279;
∙ sodium chloride 263.0 g / l , calcium chloride 7.49 g / l , magnesium chloride 2.12 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l , potassium chloride 6.70 g / l;
∙ 2006-04-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02272628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75812
∙ ACID CONCENTRATE A1224;
∙ sodium chloride 263.0 g / l , potassium chloride 10.1 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2005-07-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254301
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73921
∙ ACID CONCENTRATE A1223;
∙ sodium chloride 263.0 g / l , potassium chloride 10.1 g / l , calcium chloride 7.47 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2005-07-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254328
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73922
∙ ACID CONCENTRATE A1294;
∙ sodium chloride 263.0 g / l , potassium chloride 13.47 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2005-07-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02268728
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75411
∙ ACID CONCENTRATE A1261;
∙ sodium chloride 263.0 g / l , potassium chloride 3.35 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2010-06-22;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02262479
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74786
∙ ACID CONCENTRATE A1227;
∙ sodium chloride 263.0 g / l , potassium chloride 3.35 g / l , calcium chloride 6.24 g / l , magnesium chloride 2.14 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2005-07-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254247
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73916
∙ ACID CONCENTRATE A1221;
∙ sodium chloride 263.0 g / l , potassium chloride 3.35 g / l , calcium chloride 7.47 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2005-07-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254344
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73924
∙ ACID CONCENTRATE A1229;
∙ sodium chloride 263.0 g / l , potassium chloride 3.35 g / l , calcium chloride 7.47 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 99.0 g / l;
∙ 2007-01-10;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02262460
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74785
∙ ACID CONCENTRATE A1226;
∙ sodium chloride 263.0 g / l , potassium chloride 6.71 g / l , calcium chloride 5.0 g / l , magnesium chloride 2.14 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2005-08-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254255
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73917
∙ ACID CONCENTRATE A1262;
∙ sodium chloride 263.0 g / l , potassium chloride 6.71 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2006-04-16;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02262487
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74787
∙ ACID CONCENTRATE A1225;
∙ sodium chloride 263.0 g / l , potassium chloride 6.71 g / l , calcium chloride 6.24 g / l , magnesium chloride 3.21 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2005-07-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254298
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73919
∙ ACID CONCENTRATE A1228;
∙ sodium chloride 263.0 g / l , potassium chloride 6.71 g / l , calcium chloride 7.47 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 99.0 g / l;
∙ 2005-07-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254239
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73915
∙ ACID CONCENTRATE A1222;
∙ sodium chloride 263.0 g / l , potassium chloride 6.71 g / l , calcium chloride 7.47 g / l , magnesium chloride 3.21 g / l , acetic acid 10.81 g / l , dextrose 49.5 g / l;
∙ 2005-07-12;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254336
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73923
∙ NATURALYTE H-616;
∙ sodium chloride 263.0 g / l , potassium chloride 6.71 g / l , calcium chloride 8.27 g / l , magnesium chloride 3.43 g / l , acetic acid 10.81 g / l , dextrose 98.99 g / l;
∙ 2010-05-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC;
∙ DIN: 02327066
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81238
∙ ACID CONCENTRATE A1246;
∙ sodium chloride 268 g / l , potassium chloride 3.35 g / l , calcium chloride 6.24 g / l , magnesium chloride 3.21 g / l , acetic acid 10.81 g / l , dextrose 99 g / l;
∙ 2018-09-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254360
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73926
∙ ACID CONCENTRATE A1243;
∙ sodium chloride 268.0 g / l , potassium chloride 10.1 g / l , calcium chloride 7.74 g / l , magnesium chloride 3.21 g / l , acetic acid 10.81 g / l , dextrose 99.0 g / l;
∙ 2006-04-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254093
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73902
∙ ACID CONCENTRATE A1242;
∙ sodium chloride 268.0 g / l , potassium chloride 6.71 g / l , calcium chloride 7.74 g / l , magnesium chloride 3.21 g / l , acetic acid 10.81 g / l , dextrose 99.0 g / l;
∙ 2006-03-27;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254379
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73927
∙ ACID CONCENTRATE A1253;
∙ sodium chloride 275 g / l , potassium chloride 10.1 g / l , calcium chloride 6.24 g / l , magnesium chloride 1.61 g / l , acetic acid 8.11 g / l , dextrose 99 g / l;
∙ 2006-08-28;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02248823
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73193
∙ ACID CONCENTRATE A1230;
∙ sodium chloride 275.0 g / l , calcium chloride 6.24 g / l , magnesium chloride 3.21 g / l , acetic acid 10.81 g / l , dextrose 74.25 g / l;
∙ 2005-08-17;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254085
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73901
∙ ACID CONCENTRATE A1231;
∙ sodium chloride 275.0 g / l , potassium chloride 5.02 g / l , calcium chloride 6.24 g / l , magnesium chloride 3.21 g / l , acetic acid 10.81 g / l , dextrose 74.25 g / l;
∙ 2006-06-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254395
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73929
∙ ACID CONCENTRATE A1255;
∙ sodium chloride 275.0 g / l , potassium chloride 5.02 g / l , calcium chloride 7.49 g / l , magnesium chloride 1.61 g / l , acetic acid 10.81 g / l , dextrose 99.0 g / l;
∙ 2006-05-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254123
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73905
∙ ACID CONCENTRATE A1252;
∙ sodium chloride 275.0 g / l , potassium chloride 6.71 g / l , calcium chloride 5.00 g / l , magnesium chloride 3.21 g / l , acetic acid 10.81 g / l , dextrose 99.0 g / l;
∙ 2006-04-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ CHIEF MEDICAL SUPPLIES LTD;
∙ DIN: 02254115
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73904
∙ EXTRANEAL;
∙ sodium chloride 5.35 g / l , sodium lactate 4.48 g / l , calcium chloride 257 mg / l , magnesium chloride 51 mg / l , icodextrin 75 g / l;
∙ 2000-01-20;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intraperitoneal | Intrapéritonéale;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02240806
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64397
∙ BALANCE 2.3% GLUCOSE, 1.25 MMOL/L CALCIUM;
∙ sodium chloride 5.64 g / l , sodium lactate 3.925 g / l , calcium chloride 0.1838 g / l , magnesium chloride 0.1017 g / l , dextrose 25 g / l;
∙ 2006-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE CANADA INC;
∙ DIN: 02261073
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74649
∙ BALANCE 4.25% GLUCOSE, 1.25 MMOL/L CALCIUM;
∙ sodium chloride 5.64 g / l , sodium lactate 3.925 g / l , calcium chloride 0.1838 g / l , magnesium chloride 0.1017 g / l , dextrose 46.75 g / l;
∙ 2006-01-03;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS MEDICAL CARE CANADA INC;
∙ DIN: 02261065
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74648
∙ PLASMA-LYTE A INJECTION;
∙ sodium chloride 526 mg / 100 ml , sodium acetate 368 mg / 100 ml , sodium gluconate 502 mg / 100 ml , potassium chloride 37 mg / 100 ml , magnesium chloride 30 mg / 100 ml;
∙ 2010-12-23;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02339358
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82495
∙ ISOLYTE S (MULTI-ELECTROLYTE INJECTION);
∙ sodium chloride 530 mg / 100 ml , sodium gluconate 500 mg / 100 ml , sodium acetate 370 mg / 100 ml , potassium chloride 37 mg / 100 ml , magnesium chloride 30 mg / 100 ml;
∙ 1992-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ B. BRAUN MEDICAL INC;
∙ DIN: 01931628
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12741
∙ TIS-U-SOL SOLUTION;
∙ sodium chloride 800 mg / 100 ml , potassium chloride 40 mg / 100 ml , magnesium sulfate 20 mg / 100 ml , sodium phosphate dibasic 8.75 mg / 100 ml , potassium phosphate monobasic 6.25 mg / 100 ml;
∙ 1990-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Irrigation | Irrigation;
∙ Liquid | Liquide;
∙ 40:36.00 – IRRIGATING SOLUTIONS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 00800007
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10939
∙ BSS STERILE IRRIGATING SOLUTION;
∙ sodium citrate dihydrate 0.17 % , sodium chloride 0.64 % , potassium chloride 0.075 % , calcium chloride 0.048 % , magnesium chloride 0.03 % , sodium acetate trihydrate 0.39 %;
∙ 1980-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Irrigation | Irrigation;
∙ Solution | Solution;
∙ 52:92.00 – EENT DRUGS, MISCELLANEOUS;
∙ Ethical | Spécialité Médicale;
∙ ALCON CANADA INC;
∙ DIN: 00512990
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6366
∙ NXSTAGE PUREFLOW SOLUTION RFP-204-CAN;
∙ sodium lactate 7.473 g / l , calcium chloride 0.221 g / l , potassium chloride 0.075 g / l , dextrose 1.1 g / l , magnesium chloride 0.102 g / l , sodium chloride 5.844 g / l;
∙ 2016-09-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ NXSTAGE MEDICAL INC;
∙ DIN: 02443279
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92790
∙ NXSTAGE PUREFLOW SOLUTION RFP-207-CAN;
∙ sodium lactate 8.408 g / l , calcium chloride 0.221 g / l , potassium chloride 0.075 g / l , dextrose 1.1 g / l , magnesium chloride 0.102 g / l , sodium chloride 5.552 g / l;
∙ 2016-09-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ NXSTAGE MEDICAL INC;
∙ DIN: 02443287
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92791
∙ NXSTAGE PUREFLOW SOLUTION RFP-209-CAN;
∙ sodium lactate 8.408 g / l , calcium chloride 0.221 g / l , potassium chloride 0.15 g / l , dextrose 1.1 g / l , magnesium chloride 0.102 g / l , sodium chloride 5.552 g / l;
∙ 2016-09-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Dialysis | Dialyse;
∙ Solution | Solution;
∙ 40:34.00* – HEMODIALYSIS SOLUTION;
∙ Ethical | Spécialité Médicale;
∙ NXSTAGE MEDICAL INC;
∙ DIN: 02443295
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92792
∙ SMOFKABIVEN ELECTROLYTE FREE;
∙ soybean oil 1.14 g / 100 ml , medium chain triglycerides (mct) 1.14 g / 100 ml , olive oil 0.95 g / 100 ml , fish oil 0.57 g / 100 ml , dextrose 12.7 g / 100 ml , lysine (lysine acetate) 0.34 g / 100 ml , phenylalanine 0.26 g / 100 ml , leucine 0.38 g / 100 ml , valine 0.31 g / 100 ml , threonine 0.22 g / 100 ml , methionine 0.22 g / 100 ml , isoleucine 0.25 g / 100 ml , tryptophan 0.1 g / 100 ml , alanine 0.71 g / 100 ml , arginine 0.61 g / 100 ml , glycine 0.56 g / 100 ml , proline 0.57 g / 100 ml , histidine 0.15 g / 100 ml , serine 0.33 g / 100 ml , taurine 0.05 g / 100 ml , tyrosine 0.02 g / 100 ml;
∙ 2015-09-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 21.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02440687
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92505
∙ SMOFKABIVEN;
∙ soybean oil 1.14 g / 100 ml , medium chain triglycerides (mct) 1.14 g / 100 ml , olive oil 0.95 g / 100 ml , fish oil 0.57 g / 100 ml , dextrose 12.7 g / 100 ml , lysine (lysine acetate) 0.34 g / 100 ml , phenylalanine 0.26 g / 100 ml , leucine 0.38 g / 100 ml , valine 0.31 g / 100 ml , threonine 0.22 g / 100 ml , methionine 0.22 g / 100 ml , isoleucine 0.25 g / 100 ml , tryptophan 0.1 g / 100 ml , alanine 0.71 g / 100 ml , arginine 0.61 g / 100 ml , glycine 0.56 g / 100 ml , proline 0.57 g / 100 ml , histidine 0.15 g / 100 ml , serine 0.33 g / 100 ml , taurine 0.05 g / 100 ml , tyrosine 0.02 g / 100 ml , sodium acetate trihydrate 0.17 g / 100 ml , potassium chloride 0.23 g / 100 ml , sodium glycerophosphate 0.21 g / 100 ml , magnesium sulfate 0.061 g / 100 ml , calcium chloride 0.028 g / 100 ml , zinc sulfate heptahydrate 0.00066 g / 100 ml;
∙ 2015-09-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 27.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02440695
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92506
∙ SMOFKABIVEN PERIPHERAL;
∙ soybean oil 850 mg / 100 ml , medium chain triglycerides (mct) 850 mg / 100 ml , magnesium sulfate 38 mg / 100 ml , calcium chloride 18 mg / 100 ml , zinc sulfate heptahydrate 0.4 mg / 100 ml , dextrose 7.1 g / 100 ml , olive oil 700 mg / 100 ml , fish oil 420 mg / 100 ml , lysine (lysine acetate) 210 mg / 100 ml , phenylalanine 160 mg / 100 ml , leucine 230 mg / 100 ml , valine 200 mg / 100 ml , threonine 140 mg / 100 ml , methionine 130 mg / 100 ml , isoleucine 160 mg / 100 ml , tryptophan 63 mg / 100 ml , alanine 440 mg / 100 ml , arginine 380 mg / 100 ml , glycine 350 mg / 100 ml , proline 350 mg / 100 ml , histidine 93 mg / 100 ml , serine 210 mg / 100 ml , taurine 32 mg / 100 ml , tyrosine 12 mg / 100 ml , sodium acetate trihydrate 110 mg / 100 ml , potassium chloride 140 mg / 100 ml , sodium glycerophosphate 130 mg / 100 ml;
∙ 2017-02-14;
∙ Number of active ingredients | Nombre d’ingrédients actifs 27.00;
∙ Intravenous | Intraveineuse;
∙ Emulsion | Émulsion;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ FRESENIUS KABI CANADA LTD;
∙ DIN: 02456206
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94308
∙ ALLERGENIC EXTRACTS – 7 GRASS MIX;
∙ standardized orchard grass pollen 100000 unit / ml , standardized perennial rye grass pollen 100000 unit / ml , standardized redtop grass pollen 100000 unit / ml , standardized sweet vernal grass pollen 100000 unit / ml , standardized timothy grass pollen 100000 unit / ml , standardized kentucky blue/june grass pollen 100000 unit / ml , standardized meadow fescue grass pollen 100000 unit / ml;
∙ 2014-06-02;
∙ Number of active ingredients | Nombre d’ingrédients actifs 7.00;
∙ Subcutaneous | Sous-Cutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ GREER LABORATORIES INC;
∙ DIN: 02425513
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91016
∙ ALLERGENIC EXTRACT – MIXTURE OF 5 STANDARDIZED GRASS POLLEN;
∙ standardized timothy grass pollen 20000 unit / ml , standardized orchard grass pollen 20000 unit / ml , standardized kentucky blue/june grass pollen 20000 unit / ml , standardized redtop grass pollen 20000 unit / ml , standardized sweet vernal grass pollen 20000 unit / ml;
∙ 2009-07-30;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Intradermal , Subcutaneous , Percutaneous | Intradermique , Sous-Cutanée , Percutanée;
∙ Liquid | Liquide;
∙ 92:05.00* – ALLERGENIC EXTRACTS;
∙ Schedule D | Annexe D;
∙ ALK-ABELLO INC;
∙ DIN: 02325543
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81092
∙ ANTHELIOS DERMO-KIDS;
∙ titanium dioxide 5.85 % / w/w , octisalate 5 % / w/w , drometrizole trisiloxane 4.5 % / w/w , avobenzone 3 % / w/w , octocrylene 2.5 % / w/w , terephthalylidene dicamphor sulfonic acid 1.5 % / w/w;
∙ 2015-05-04;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Topical | Topique;
∙ Lotion | Lotion;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ LABORATOIRES LA ROCHE-POSAY CANADA;
∙ DIN: 02433052
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91746
∙ CLINIMIX E;
∙ tryptophan 90 mg / 100 ml , l-proline 210 mg / 100 ml , l-tyrosine 20 mg / 100 ml , potassium phosphate dibasic 261 mg / 100 ml , sodium chloride 58.5 mg / 100 ml , magnesium chloride 24 mg / 100 ml , sodium acetate 205 mg / 100 ml , dextrose 20 g / 100 ml , l-leucine hydrochloride 310 mg / 100 ml , l-phenylalanine hydrochloride 310 mg / 100 ml , l-lysine hydrochloride 290 mg / 100 ml , methionine 290 mg / 100 ml , l-alanine 1.04 g / 100 ml , glycine 1.04 g / 100 ml , l-arginine 520 mg / 100 ml , l-isoleucine 240 mg / 100 ml , l-valine 230 mg / 100 ml , histidine 220 mg / 100 ml , l-threonine 210 mg / 100 ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 19.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS , 40:20.00 – CALORIC AGENTS;
∙ Ethical | Spécialité Médicale;
∙ BAXTER CORPORATION;
∙ DIN: 02014068
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15868
∙ DUKORAL;
∙ vibrio cholerae ogawa 50 classical biotype – formalin inactivated 31250000000 cells / dose , recombinant cholera toxin b subunit 1 mg / dose , vibrio cholerae inaba 6973 el tor biotype – formalin inactivated 31250000000 cells / dose , vibrio cholerae inaba 48 classical biotype – heat inactivated 31250000000 cells / dose , vibrio cholerae ogawa 50 classical biotype – heat inactivated 31250000000 cells / dose;
∙ 2003-04-15;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Oral | Orale;
∙ Suspension | Suspension;
∙ 80:12.00 – VACCINES;
∙ Schedule D | Annexe D;
∙ VALNEVA SWEDEN AB;
∙ DIN: 02247208
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71450
∙ MICRO PLUS 6 (PEDIATRIC);
∙ zinc (zinc sulfate) 3 mg / ml , copper (cupric sulfate) 0.4 mg / ml , manganese (manganese sulfate) 0.1 mg / ml , chromium (chromic chloride) 4 mcg / ml , selenium (selenious acid) 20 mcg / ml , iodine (sodium iodide) 60 mcg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02091100
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16226
∙ MICRO PLUS 6 (CONCENTRATE);
∙ zinc (zinc sulfate) 5 mg / ml , copper (cupric sulfate) 1 mg / ml , manganese (manganese sulfate) 0.5 mg / ml , chromium (chromic chloride) 10 mcg / ml , selenium (selenious acid) 60 mcg / ml , iodine (sodium iodide) 75 mcg / ml;
∙ 1994-12-31;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intravenous | Intraveineuse;
∙ Liquid | Liquide;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02091127
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16227
∙ MICRO+6 CONCENTRATE;
∙ zinc (zinc sulfate) 5 mg / ml , copper (cupric sulfate) 300 mcg / ml , manganese (manganese sulfate) 55 mcg / ml , chromium (chromic chloride) 10 mcg / ml , selenium (selenium dioxide) 60 mcg / ml , iodine (sodium iodide) 75 mcg / ml;
∙ 2021-06-18;
∙ Number of active ingredients | Nombre d’ingrédients actifs 6.00;
∙ Intravenous | Intraveineuse;
∙ Solution | Solution;
∙ 40:12.00 – REPLACEMENT PREPARATIONS;
∙ Ethical | Spécialité Médicale;
∙ SANDOZ CANADA INCORPORATED;
∙ DIN: 02507587
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99695
∙ CC SUNSCREEN;
∙ zinc oxide 11.652 % / w/w , octinoxate 7 % / w/w , titanium dioxide 4.565 % / w/w , octisalate 4.5 % / w/w , ensulizole 3.5 % / w/w;
∙ 2019-05-13;
∙ Number of active ingredients | Nombre d’ingrédients actifs 5.00;
∙ Topical | Topique;
∙ Cream | Crème;
∙ 84:80.00 – SUNSCREEN AGENTS;
∙ Otc | En Vente Libre;
∙ THE AVON COMPANY CANADA LIMITED;
∙ DIN: 02474581
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96481

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut